Loading...
Docoh

Mentor Capital (MNTR)

Document and Entity Information

Document and Entity Information - shares3 Months Ended
Mar. 31, 2021May 03, 2021
Details
Registrant CIK0001599117
Fiscal Year End--12-31
Document Type10-Q
Document Quarterly Reporttrue
Document Period End DateMar. 31,
2021
Document Transition Reportfalse
Entity File Number000-55323
Entity Registrant NameMentor Capital, Inc.
Entity Incorporation, State or Country CodeDE
Entity Tax Identification Number77-0395098
Entity Address, Address Line One5964 Campus Court
Entity Address, City or TownPlano
Entity Address, State or ProvinceTX
Entity Address, Postal Zip Code75093
Entity Address, Address DescriptionAddress of principal executive offices
Phone Fax Number DescriptionRegistrant’s telephone number, including area code
City Area Code760
Local Phone Number788-4700
Entity Current Reporting StatusYes
Entity Interactive Data CurrentYes
Entity Filer CategoryNon-accelerated Filer
Entity Small Businesstrue
Entity Emerging Growth Companytrue
Entity Ex Transition Periodfalse
Entity Shell Companyfalse
Entity Common Stock, Shares Outstanding22,850,947
Amendment Flagfalse
Document Fiscal Year Focus2021
Document Fiscal Period FocusQ1

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)Mar. 31, 2021Dec. 31, 2020
Current assets
Cash and cash equivalents $ 444,239 $ 506,174
Investment in securities, at fair value39,676 34,826
Accounts receivable, net527,796 508,286
Net finance leases receivable, current portion70,896 69,053
Investment in installment receivable, current portion84,662 26,162
Convertible notes receivable, current portion26,774 26,454
Prepaid expenses and other current assets144,138 17,839
Employee advances and other receivable200 1,050
Total current assets1,338,381 1,189,844
Property and equipment
Property and equipment275,019 267,160
Accumulated depreciation and amortization(139,395)(129,974)
Property and equipment, net135,624 137,186
Other assets
Operating lease right-of-use assets143,936 129,295
Finance lease right-of-use assets529,143 296,078
Investment in account receivable, net of discount and current portion260,624 303,896
Net finance leases receivable, net of current portion286,756 306,898
Convertible notes receivable, net of current portion56,257 55,584
Contractual interest in legal recovery381,529 381,529
Deposits9,575 9,575
Long term investments205,028 205,028
Goodwill1,426,182 1,426,182
Total other assets3,299,030 3,114,065
Total assets4,773,035 4,441,095
Current liabilities
Accounts payable48,466 18,813
Accrued expenses367,375 259,934
Related party payable20,000 20,000
Deferred revenue14,573 16,198
Paycheck protection program loans, current portion0 6,658
Finance lease liability, current portion119,542 79,526
Operating lease liability, current portion121,588 123,158
Current portion of long-term debt15,696 15,566
Total current liabilities707,240 539,853
Long-term liabilities
Accrued salary, retirement, and incentive fee - related party1,105,669 1,137,334
Related party loan100,196 0
Paycheck protection program loans, net of current portion76,681 2,791
Economic injury disaster loan153,993 152,602
Finance lease liability, net of current portion351,778 190,976
Operating lease liability, net of current portion32,919 16,150
Long term debt, net of current portion62,287 66,246
Total long-term liabilities1,883,523 1,566,099
Total liabilities2,590,763 2,105,952
Commitments and Contingencies0 0
Shareholders' equity
Preferred Stock, Value, Issued[1]0 0
Common Stock, Value, Issued2,285 2,285
Additional paid in capital13,071,655 13,071,655
Accumulated deficit(10,748,154)(10,601,231)
Non-controlling interest(143,514)(137,566)
Total shareholders' equity2,182,272 2,335,143
Total liabilities and shareholders' equity $ 4,773,035 $ 4,441,095
[1]* Par value is less than $0.01.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) - Parenthetical - $ / sharesMar. 31, 2021Dec. 31, 2020
Details
Preferred Stock, Par or Stated Value Per Share[1] $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized[1]5,000,000 5,000,000
Preferred Stock, Shares Issued[1]11 11
Preferred Stock, Shares Outstanding[1]11 11
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized75,000,000 75,000,000
Common Stock, Shares, Issued22,850,947 22,850,947
Common Stock, Shares, Outstanding22,850,947 22,850,947
[1]* Par value is less than $0.01.

Condensed Consolidated Income S

Condensed Consolidated Income Statements (Unaudited) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Revenue
Service fees $ 1,309,753 $ 1,136,924
Finance lease revenue10,871 12,538
Total revenue1,320,624 1,149,462
Cost of sales884,232 764,360
Gross profit436,392 385,102
Selling, general and administrative expenses601,135 621,825
Operating (loss)(164,743)(236,723)
Other income and (expense)
Gain (loss) on investments in securities4,849 (10,206)
Paycheck Protection Program loan forgiven10,000 0
Interest income16,489 19,403
Interest expense(12,070)(7,337)
Gain (loss) on ROU asset disposal(643)0
Other income (expense)(1,053)12,084
Total other income and (expense)17,572 13,944
Loss before provision for income taxes(147,171)(222,779)
Provision for income taxes5,700 11,178
Net (loss)(152,871)(233,957)
Gain (loss) attributable to non-controlling interest(5,948)13,813
Net Income (Loss) $ (146,923) $ (247,770)
Earnings Per Share, Basic and Diluted $ (0.006) $ (0.011)
Weighted Average Number of Shares Outstanding, Basic and Diluted[1]22,850,947 22,850,947
[1]The company recorded an operating loss; therefore the diluted EPS will not be calculated as the diluted EPS effect is anti-dilutive.

Condensed Consolidated Statemen

Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)Preferred Stock[1]Common StockAdditional Paid-in CapitalRetained EarningsParentNoncontrolling InterestTotal
Equity Balance, Starting at Dec. 31, 2019 $ 0 $ 2,285 $ 13,071,655 $ (9,875,206) $ 3,198,734 $ (186,050) $ 3,012,684
Shares Outstanding, Starting at Dec. 31, 201911 22,850,947
Net Income (Loss) $ 0 0 (247,770)(247,770)13,813 (233,957)
Shares Outstanding, Ending at Mar. 31, 202011 22,850,947
Equity Balance, Ending at Mar. 31, 2020 $ 0 $ 2,285 13,071,655 (10,122,976)2,950,964 (172,237)2,778,727
Equity Balance, Starting at Dec. 31, 2020 $ 2,285 13,071,655 (10,601,231)2,472,709 (137,566)2,335,143
Shares Outstanding, Starting at Dec. 31, 202011 22,850,947
Net Income (Loss) $ 0 0 (146,923)(146,923)(5,948)(152,871)
Shares Outstanding, Ending at Mar. 31, 202111 22,850,947
Equity Balance, Ending at Mar. 31, 2021 $ 0 $ 2,285 $ 13,071,655 $ (10,748,154) $ 2,325,786 $ (143,514) $ 2,182,272
[1]Par value of series Q preferred shares is less than $1.

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) $ (152,871) $ (233,957)
cash provided by (used by) operating activities:
Depreciation and amortization9,421 3,842
Non-cash amortization of right of use asset29,076 17,199
PPP loan forgiven(10,000)0
(Gain) loss on ROU asset disposal643 0
Bad debt expense6,170 22,069
Amortization of discount on investment in account receivable(15,228)(18,345)
Increase in accrued investment interest income(993)(957)
(Gain) loss on investment in securities, at fair value(4,849)5,037
Gain on long-term investments0 5,169
Decrease (increase) in operating assets
Finance leases receivable18,299 238,642
Accounts receivable - trade(25,681)61,575
Prepaid expenses and other current assets(126,299)13,585
Employee advances850 668
Increase (decrease) in operating liabilities
Accounts payable29,653 (37,408)
Accrued expenses109,116 81,239
Deferred revenue(1,625)(1,606)
Accrued salary, retirement, and benefits - related party(31,665)7,064
Net cash provided by (used by) operating activities(165,983)163,816
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investment securities0 (38,115)
Purchase contractual interest in legal recovery0 (50,717)
Purchases of property and equipment(7,859)(3,329)
Down payments on right of use assets(37,834)(9,604)
Proceeds from investment in receivable0 4,000
Net cash (used by) investing activities(45,693)(97,765)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from related party loan100,000 0
Proceeds from paycheck protection program loans76,593 0
Refund of Paycheck Protection Program payments551 0
Payments on related party payable0 (27,472)
Payments on long-term debt(3,829)(6,361)
Payments on finance lease liabilities(23,574)(10,961)
Net cash provided by (used by) financing activities149,741 (44,794)
Net change in cash(61,935)21,257
Beginning cash506,174 686,611
Ending cash444,239 707,868
SUPPLEMENTARY INFORMATION:
Cash paid for interest7,889 7,337
Cash paid for income taxes740 4,800
NON-CASH INVESTING AND FINANCING TRANSACTIONS:
Right of use assets acquired through operating lease liability55,624 0
Right of use assets acquired through finance lease liability $ 224,392 $ 80,779

Note 1 - Nature of operations

Note 1 - Nature of operations3 Months Ended
Mar. 31, 2021
Notes
Note 1 - Nature of operationsNote 1 - Nature of operations Corporate Structure Overview Mentor Capital, Inc. (“Mentor” or “the Company”), reincorporated under the laws of the State of Delaware in September 2015. The entity was originally founded as an investment partnership in Silicon Valley, California, by the current CEO in 1985 and subsequently incorporated under the laws of the State of California on July 29, 1994. On September 12, 1996, the Company’s offering statement was qualified pursuant to Regulation A of the Securities Act, and the Company began to trade its shares publicly. On August 21, 1998, the Company filed for voluntary reorganization, and on January 11, 2000, the Company emerged from Chapter 11 reorganization. The Company relocated to San Diego, California, and contracted to provide financial assistance and investment into small businesses. On May 22, 2015, a corporation named Mentor Capital, Inc. (“Mentor Delaware”) was incorporated under the laws of the State of Delaware. A shareholder-approved merger between Mentor and Mentor Delaware was approved by the California and Delaware Secretaries of State and became effective September 24, 2015, thereby establishing Mentor as a Delaware corporation. In September 2020, Mentor relocated its corporate office from San Diego, California, to Plano, Texas. The Company’s common stock trades publicly under the trading symbol OTCQB: MNTR. The Company’s target industry focus includes energy, mining and minerals, technology, consumer products, management services, and manufacturing sectors with the goal of ensuring increased market opportunities and investment diversification. In April 2021, the Company announced that it is adding a cryptocurrency and Bitcoin focus for any ongoing excess cash of Mentor. Mentor has a 51% interest in Waste Consolidators, Inc. (“WCI”). WCI was incorporated in Colorado in 1999 and operates in Arizona and Texas. It is a long standing investment of the Company since 2003. On April 18, 2016, the Company formed Mentor IP, LLC (“MCIP”), a South Dakota limited liability company and wholly owned subsidiary of Mentor. MCIP was formed to hold interests related to patent rights obtained on April 4, 2016, when Mentor Capital, Inc. entered into that certain "Larson - Mentor Capital, Inc. Patent and License Fee Facility with Agreement Provisions for an -- 80% / 20% Domestic Economic Interest -- 50% / 50% Foreign Economic Interest" with R. L. Larson and Larson Capital, LLC (“MCIP Agreement”). Pursuant to the MCIP Agreement, MCIP obtained rights to an international patent application for foreign THC and CBD cannabis vape pens under the provisions of the Patent Cooperation Treaty of 1970, as amended. R. L. Larson continues its efforts to obtain exclusive licensing rights in the United States for THC and CBD cannabis vape pens for various THC and CBD percentage ranges and concentrations. On May 5, 2020, a patent was issued by the United States Patent and Trademark Office and on September 22, 2020, a patent was issued by the Canadian Intellectual Property Office. Patent application national phase maintenance fees were expensed when paid rather than capitalized and therefore, no capitalized assets related to MCIP are recognized on the consolidated financial statements at March 31, 2021 and December 31, 2020. Mentor Partner I, LLC (“Partner I”) was reorganized as a limited liability company under the laws of the State of Texas as of February 17, 2021. The entity was initially organized as a limited liability company under the laws of the State of California on September 19, 2017. Partner I was formed as a wholly owned subsidiary of Mentor for the purpose of cannabis-focused acquisition and investment. In 2018, Mentor contributed $996,000 of capital to Partner I to facilitate the purchase of manufacturing equipment to be leased from Partner I by G FarmaLabs Limited (“G Farma”) under a Master Equipment Lease Agreement dated January 16, 2018, as amended. Amendments expanded the Lessee under the agreement to include G FarmaLabs Limited and G FarmaLabs DHS, LLC, (collectively referred to as “G Farma Lease Entities”). The finance leases resulting from this investment were fully impaired at March 31, 2021 and December 31, 2020. See Note 8. Mentor Partner II, LLC (“Partner II”) was reorganized as a limited liability company under the laws of the State of Texas on February 17, 2021. The entity was initially organized as a limited liability under the laws of the State of California on February 1, 2018. Partner II was formed as a wholly owned subsidiary of Mentor for the purpose of cannabis-focused investing and acquisition. On February 8, 2018, Mentor contributed $400,000 to Partner II to facilitate the purchase of manufacturing equipment to be leased from Partner II by Pueblo West Organics, LLC, a Colorado limited liability company (“Pueblo West”) under a Master Equipment Lease Agreement dated February 11, 2018, as amended. On March 12, 2019, Mentor agreed to use Partner II earnings of $61,368 to facilitate the purchase of additional manufacturing equipment to Pueblo West under a Second Amendment to the lease. This lease is fully performing, see Note 8. The Company has a membership equity interest in Electrum Partners, LLC (“Electrum”) which is carried at a cost of $194,028 and $194,028 at March 31, 2021 and December 31, 2020, respectively. On October 30, 2018, the Company entered into a Recovery Purchase Agreement with Electrum. Electrum is the plaintiff in an ongoing legal action pending in the Supreme Court of British Columbia (“Litigation”). As described further in Note 9, Mentor provided capital for payment of Litigation costs in the amount of $181,529 and $146,195 as of December 31, 2020 and 2019, respectively. After repayment to Mentor of all funds invested for payment of Litigation costs, Mentor will receive 18% of anything of value received by Electrum as a result of the Litigation (“Recovery”), after first receiving reimbursement of the Litigation costs. On October 31, 2018, Mentor entered into a secured Capital Agreement with Electrum and invested an additional $100,000 of capital in Electrum. Under the Capital Agreement, on the payment date, Electrum will pay Mentor the sum of (i) $100,000, (ii) ten percent (10%) of the Recovery, and (iii) 0.083334% of the Recovery for each full month from October 31, 2018 to the payment date for each full month that $833 is not paid to Mentor. The payment date is the earlier of November 1, 2021, or the final resolution of the Litigation. On January 28, 2019, the Company entered into a second secured Capital Agreement with Electrum and invested an additional $100,000 of capital in Electrum with payment terms similar to the October 31, 2018 Capital Agreement. As part of the January 28, 2019 Capital Agreement, Mentor was granted an option to convert its 6,198 membership interests in Electrum into a cash payment of $194,027 plus an additional 19.4% of the Recovery. See Note 9. On December 21, 2018, Mentor paid $10,000 to purchase 500,000 shares of NeuCourt, Inc. common stock, representing approximately 6.1% of NeuCourt’s issued and outstanding common stock as of March 31, 2021.

Note 2 - Summary of significant

Note 2 - Summary of significant accounting policies3 Months Ended
Mar. 31, 2021
Notes
Note 2 - Summary of significant accounting policiesNote 2 - Summary of significant accounting policies Condensed consolidated financial statements The unaudited condensed consolidated financial statements of the Company for the three month period ended March 31, 2021 and 2020 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-K. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of December 31, 2020 was derived from the audited financial statements included in the Company's financial statements as of and for the year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on April 15, 2021. These financial statements should be read in conjunction with that report. Basis of presentation The accompanying consolidated financial statements and related notes include the activity of subsidiaries in which a controlling financial interest is owned. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Significant intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform with the current period presentation. As shown in the accompanying financial statements, the Company has a significant accumulated deficit of $10,748,154 as of March 31, 2021. The Company continues to experience negative cash flows from operations. The Company management believes it is more likely than not that Electrum will prevail in the legal action described in Note 9 to the consolidated financial statements, in which the Company has an interest. However, there is no surety that Electrum will prevail in its legal action or that we will be able to recover our funds and our percentage of the Litigation Recovery if Electrum does prevail. The Company will be required to raise additional capital to fund its operations and will continue to attempt to raise capital resources from both related and unrelated parties until such time as the Company is able to generate revenues sufficient to maintain itself as a viable entity. These factors have raised substantial doubt about the Company's ability to continue as a going concern. These financial statements are presented on the basis that we will continue as a going concern. The going concern concept contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. There can be no assurances that the Company will be able to raise additional capital or achieve profitability. However, the Company has approximately 6.2 million warrants outstanding in which the Company can reset the exercise price substantially below the current market price. These condensed consolidated financial statements do not include any adjustments that might result from repricing the outstanding warrants. Management's plans include increasing revenues through acquisition, investment, and organic growth. Management anticipates funding these activities by raising additional capital through the sale of equity securities and debt. Impact Related to COVID-19 The effect of the novel coronavirus (“COVID-19”) has significantly impacted the United States and the global economy. COVID-19 and the measures taken by many countries in response have adversely affected and could in the future materially adversely impact the Company’s business, results of operations, financial condition, and stock price. As of March 31, 2021, the impact of COVID-19 continues to unfold. The ongoing worldwide economic situation, future weakness in the credit markets, and significant liquidity problems for the financial services industry may impact our financial condition in a number of ways. For example, our current or potential customers, or the current or potential customers of our partners or affiliates, may delay or decrease spending with us, or may not pay us, or may delay paying us for previously purchased products and services. Also, we, or our partners or affiliates, may have difficulties in securing additional financing. Our legal recovery efforts have been hindered and may continue to be constrained, due to the closure of the courts in California and British Columbia, which may cause COVID-19-related scheduling delays, hindering our legal recovery from the G Farma Entities and delaying the receipt of the Company’s interest in the Electrum Partners, LLC legal recovery, respectively. Additionally, the collectability of our investment in accounts receivable has been impaired by $139,148 in the fourth quarter of 2020, due to a reduction in our expected collection amount of the 2020 and 2021 payments of an installment contract, see Note 4. Public health efforts to mitigate the impact of COVID-19 have included government actions such as travel restrictions, limitations on public gatherings, shelter in place orders, and mandatory closures. These actions are being lifted to varying degrees. WCI has not experienced an overall reduced demand for services initially anticipated because WCI helps lower monthly service costs paid by its client properties. However, WCI’s clients may experience a delay in collecting rent from tenants, which may cause slower payments to WCI. WCI closely monitors customer accounts and has not experienced significant delays in the collection of accounts receivable. According to the Critical Infrastructure Standards released by the Cybersecurity and Infrastructure Security Agency on March 18, 2020, “Financial Services Sector” businesses, like Mentor, are considered “essential businesses.” Because of the financial nature of Mentor’s operations, which consist of oversight of our portfolio companies, accounting, compliance, investor relations, and sales, Mentor’s day-to-day operations are not substantially hindered by remote office work or telework. We anticipate that current cash resources will be sufficient for us to execute our business plan for the next 9 months. The ultimate impact of COVID-19 on our business, results of operations, financial condition and cash flows is dependent on future developments, including the duration of COVID-19 and the related length of its impact on the global economy, which are uncertain and cannot be predicted at this time. Use of estimates The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and judgments that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of our consolidated financial statements, and the reported amount of revenues and expenses during the reporting period. Significant estimates relied upon in preparing these consolidated financial statements include revenue recognition, accounts and notes receivable reserves, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to investments, goodwill, amortization periods, accrued expenses, and recoverability of the Company’s net deferred tax assets and any related valuation allowance. Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate. Recent Accounting Standards From time to time, the FASB or other standards setting bodies issue new accounting pronouncements. Updates to the FASB Accounting Standard Codifications (“ASCs”) are communicated through the issuance of an Accounting Standards Update (“ASU”). Unless otherwise discussed, we believe that the impact of recently issued guidance, whether adopted or to be adopted in the future, is not expected to have a material impact on our consolidated financial statements upon adoption. There were no accounting pronouncements issued during the three months ended March 31, 2021 that are expected to have a material impact on the Company’s condensed consolidated financial statements. Concentrations of cash The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits. The Company has not experienced any losses in such accounts, nor does the Company believe it is exposed to any significant credit risk on cash and cash equivalents. Cash and cash equivalents The Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents. The Company had no short-term debt securities as of March 31, 2021 and December 31, 2020. Accounts receivable Accounts receivables consist of trade accounts arising in the normal course of business and are classified as current assets and carried at original invoice amounts less an estimate for doubtful receivables based on historical losses as a percent of revenue in conjunction with a review of outstanding balances on a quarterly basis. The estimate of the allowance for doubtful accounts is based on the Company's bad debt experience, market conditions, and aging of accounts receivable, among other factors. If the financial condition of the Company's customers deteriorates, resulting in the customer's inability to pay the Company's receivables as they come due, additional allowances for doubtful accounts will be required. At March 31, 2021 and December 31, 2020, the Company has an allowance for doubtful receivables in the amount of $65,631 and $59,461, respectively. Investments in securities at fair value Investment in securities consists of debt and equity securities reported at fair value. Under ASU 2016-01, “ Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities Long term investments The Company’s investments in entities where it is a minority owner and does not have the ability to exercise significant influence are recorded at fair value if readily determinable. If the fair market value is not readily determinable, the investment is recorded under the cost method. Under this method, the Company’s share of the earnings or losses of such investee company is not included in the Company’s financial statements. The Company reviews the carrying value of its long-term investments for impairment each reporting period. Investments in debt securities The Company’s investment in debt securities consists of two convertible notes receivable from NeuCourt, Inc., which are recorded at the aggregate principal face amount of $75,000 plus accrued interest of $8,031 and $7,038 at March 31, 2021 and December 31, 2020, respectively, as presented in Note 7. Investment in account receivable, net of discount The Company’s investment in account receivable is stated at face value, net of unamortized purchase discount. The discount is amortized to interest income over the term of the exchange agreement. In the fourth quarter of 2020, we were notified that due to the effect of COVID-19 on the estimated receivable, we may not receive the 2020 installment payment or the full 2021 installment payment. At March 31, 2021 and December 31, 2020, the Company has an impairment of the investment in account receivable of $139,148 and $139,148, respectively. Credit quality of notes receivable and finance leases receivable, and credit loss reserve As our notes receivable and finance leases receivable are limited in number, our management is able to analyze estimated credit loss reserves based on a detailed analysis of each receivable as opposed to using portfolio-based metrics. Our management does not use a system of assigning internal risk ratings to each of our receivables. Rather, each note receivable and finance lease receivable is analyzed quarterly and categorized as either performing or non-performing based on certain factors including, but not limited to, financial results, satisfying scheduled payments, and compliance with financial covenants. A note receivable or finance lease receivable will be categorized as non-performing when a borrower experiences financial difficulty and has failed to make scheduled payments. As part of the monitoring process, we may physically inspect the collateral or a borrower’s facility and meet with a borrower’s management to better understand such borrower’s financial performance and its future plans on an as-needed basis. Lessee Leases We determine whether an arrangement is a lease at inception. Lessee leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria is met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that is reasonably certain to be exercised, and (iii) the lease term is for a significant part of the remaining useful life of the asset or the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of these criteria. Our operating leases are comprised of office space leases and office equipment. Fleet vehicle leases entered into prior to January 1, 2019, are classified as operating leases based on an expected lease term of four years. Fleet vehicle leases entered into beginning January 1, 2019, for which the lease is expected to be extended to five years, are classified as finance leases. Our leases have remaining lease terms of one to forty-eight months. Our fleet finance leases contain a residual value guarantee which, based on past lease experience, is unlikely to result in a liability at the end of the lease. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Costs associated with operating lease assets are recognized on a straight-line basis, over the term of the lease, within cost of goods sold for vehicles used in direct servicing of WCI customers and in operating expenses for costs associated with all other operating leases. Finance lease assets are amortized within cost of goods sold for vehicles used in direct servicing of WCI customers and within operating expenses for all other finance lease assets, on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease term. The interest component of a finance lease is included in interest expense and recognized using the effective interest method over the lease term. We have agreements that contain both lease and non-lease components. For vehicle fleet operating leases, we account for lease components together with non-lease components (e.g., maintenance fees). Property, and equipment Property and equipment is recorded at cost less accumulated depreciation. Depreciation is computed on the declining balance method over the estimated useful lives of various classes of property. The estimated lives of the property and equipment are generally as follows: computer equipment, three to five years; furniture and equipment, seven years; and vehicles and trailers, four to five years. Depreciation on vehicles used by WCI to service its customers is included in cost of goods sold in the consolidated income statements. All other depreciation is included in selling, general and administrative costs in the consolidated income statements. Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property and equipment may not be recoverable in accordance with the provisions of ASC 360, “Property, Plant, and Equipment.” The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified. Goodwill Goodwill of $1,324,142 was derived from consolidating WCI effective January 1, 2014, and $102,040 of goodwill related to the 1999 acquisition of a 50% interest in WCI. In accordance with ASC 350, “Intangibles-Goodwill and Other,” The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually as of December 31 and whenever events or changes in circumstances indicate carrying amount may not be recoverable. In the impairment test, the Company measures the recoverability of goodwill by comparing a reporting unit’s carrying amount, including goodwill, to the estimated fair value of the reporting unit. If the carrying amount of a reporting unit is in excess of its fair value, the Company recognizes an impairment charge equal to the amount in excess. To estimate the fair value, management uses valuation techniques which included the discounted value of estimated future cash flows. The evaluation of impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and are subject to change as future events and circumstances change. Actual results may differ from assumed and estimated amounts. Management determined that no impairment write-downs were required as of March 31, 2021 and December 31, 2020. Revenue recognition The Company recognizes revenue in accordance with ASC 606, “ Revenue from Contracts with Customers Leases WCI works with business park owners, governmental centers, and apartment complexes to reduce facilities related costs. WCI performs monthly services pursuant to agreements with customers. Customer monthly service fees are based on WCI’s assessment of the amount and frequency of monthly services requested by a customer. WCI may also provide additional services, such as apartment cleanout services, large item removals, or similar services, on an as needed basis at an agreed upon rate as requested by customers. All services are invoiced and recognized as revenue in the month the agreed on services are performed. For each finance lease, the Company recognized as a gain the amount equal to (i) the net investment in the finance lease less (ii) the net book value of the equipment at the inception of the applicable lease. At lease inception, we capitalize the total minimum finance lease payments receivable from the lessee, the estimated unguaranteed residual value of the equipment at lease termination, if any, and the initial direct costs related to the lease, less unearned income. Unearned income is recognized as finance income over the term of the lease using the effective interest rate method. The Company, through its subsidiaries, is the lessor of manufacturing equipment subject to leases under master leasing agreements. The leases contain an element of dealer profit and lessee bargain purchase options at prices substantially below the subject assets’ estimated residual values at the exercise date for the options. Consequently, the Company classified the leases as sales-type leases (the “finance leases”) for financial accounting purposes. For such finance leases, the Company reports the discounted present value of (i) future minimum lease payments (including the bargain purchase option, if any) and (ii) any residual value not subject to a bargain purchase option as a finance lease receivable on its balance sheet and accrues interest on the balance of the finance lease receivable based on the interest rate inherent in the applicable lease over the term of the lease. For each finance lease, the Company recognized revenue in an amount equal to the net investment in the lease and cost of sales equal to the net book value of the equipment at the inception of the applicable lease. Basic and diluted income (loss) per common share We compute net income (loss) per share in accordance with ASC 260, “ Earnings Per Share Outstanding warrants that had no effect on the computation of the dilutive weighted average number of shares outstanding as their effect would be anti-dilutive were approximately 7,000,000 and 7,000,000 as of March 31, 2021 and December 31, 2020, respectively. There were 87,456 and 87,456 potentially dilutive shares outstanding at March 31, 2021 and December 31, 2020, respectively. Conversion of Series Q Preferred Stock into Common Stock would be anti-dilutive for the three months ended March 31, 2021 and 2020 and is not included in calculating the diluted weighted average number of shares outstanding.

Note 3 - Prepaid expenses and o

Note 3 - Prepaid expenses and other assets3 Months Ended
Mar. 31, 2021
Notes
Note 3 - Prepaid expenses and other assetsNote 3 – Prepaid expenses and other assets Prepaid expenses and other assets consist of the following: March 31, 2021 December 31, 2020 Prepaid management fees $ 115,000 $ - Prepaid insurance 342 342 Other prepaid costs 28,796 17,497 $ 144,138 $ 17,839

Note 4 - Investment in account

Note 4 - Investment in account receivable3 Months Ended
Mar. 31, 2021
Notes
Note 4 - Investment in account receivableNote 4 – Investment in account receivable On April 10, 2015, the Company entered into an exchange agreement whereby the Company received an investment in an account receivable with annual installment payments of $117,000 for 11 years, through 2026, totaling $1,287,000 in exchange for 757,059 shares of Mentor Common Stock obtained through exercise of 757,059 Series D warrants at $1.60 per share plus a $0.10 per warrant redemption price. The Company valued the transaction based on the market value of Company common shares exchanged in the transaction, resulting in a 17.87% discount from the face value of the account receivable. The discount is being amortized monthly to interest over the 11-year term of the agreement. In the fourth quarter of 2020, we were notified that due to the effect of Covid-19 on the estimated receivable, we may not receive the 2020 installment payment or the full 2021 installment payment. Based on management’s collection estimates, we recorded an impairment of $139,148 and $139,148 on the investment in account receivable at March 31, 2021 and December 31, 2020, respectively. The investment in account receivable consists of the following at March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 Face value $ 702,000 $ 702,000 Impairment (139,148) (139,148) Unamortized discount (217,566) (232,794) Net balance 345,286 330,058 Current portion (84,662) (26,162) Long term portion $ 260,624 $ 303,896 For the three months ended March 31, 2021 and 2020, $15,228 and $18,345 of discount amortization is included in interest income, respectively.

Note 5 - Property and equipment

Note 5 - Property and equipment3 Months Ended
Mar. 31, 2021
Notes
Note 5 - Property and equipmentNote 5 - Property and equipment Property and equipment are comprised of the following: March 31, 2021 December 31, 2020 Computers $ 39,809 $ 38,545 Furniture and fixtures 23,428 23,428 Machinery and vehicles 211,782 205,187 275,019 267,160 Accumulated depreciation and amortization (139,395) (129,974) Net Property and equipment $ 135,624 $ 137,186 Depreciation and amortization expense was $9,421 and $3,842 for the three months ended March 31, 2021 and 2020, respectively. Depreciation on WCI vehicles used to service customer accounts is included in the cost of goods sold, and all other depreciation is included in selling, general and administrative expenses in the condensed consolidated income statements.

Note 6 - Lessee Leases

Note 6 - Lessee Leases3 Months Ended
Mar. 31, 2021
Notes
Note 6 - Lessee LeasesNote 6 – Lessee Leases Our operating leases are comprised of office space and office equipment leases. Fleet leases entered into prior to January 1, 2019, are classified as operating leases. Fleet leases entered into beginning January 1, 2019, under ASC 842 guidelines, are classified as finance leases. Gross right of use assets recorded under finance leases related to WCI vehicle fleet leases were $651,941 and $406,242 as of March 31, 2021 and December 31, 2020, respectively. Accumulated amortization associated with finance leases was $122,798 and $110,164 as of March 31, 2021 and December 31, 2020, respectively. Lease costs recognized in our consolidated statements of operations is summarized as follows: Three Months Ended March 31, 2021 2020 Operating lease cost included in cost of goods $ 32,864 $ 45,956 Operating lease cost included in operating costs 11,096 14,274 Total operating lease cost (1) 43,960 60,230 Finance lease cost, included in cost of goods: Amortization of lease assets 28,518 13,993 Interest on lease liabilities 5,467 3,494 Total finance lease cost 33,985 17,487 Short-term lease cost 2,300 8,970 Total lease cost $ 80,245 $ 86,687 (1) Other information about lease amounts recognized in our condensed consolidated financial statements is summarized as follows: March 31, 2021 December 31, 2020 Weighted-average remaining lease term – operating leases 1.52 years 0.93 years Weighted-average remaining lease term – finance leases 4.07 years 3.41 years Weighted-average discount rate – operating leases 9.2% 10.1% Weighted-average discount rate – finance leases 5.1% 8.3% Finance lease liabilities were as follows: March 31, 2021 December 31, 2020 Gross finance lease liabilities $ 516,408 $ 310,685 Less: imputed interest (45,088) (40,183) Present value of finance lease liabilities 471,320 270,502 Less: current portion (119,542) (79,526) Long-term finance lease liabilities $ 351,778 $ 190,976 Operating lease liabilities were as follows: March 31, 2021 December 31, 2020 Gross operating lease liabilities $ 161,153 $ 146,171 Less: imputed interest (6,646) (6,863) Present value of operating lease liabilities 154,507 139,308 Less: current portion (121,588) (123,158) Long-term operating lease liabilities $ 32,919 $ 16,150 Lease maturities were as follows: Maturity of lease liabilities 12 months ending March 31, Finance leases Operating leases 2022 $ 119,542 $ 121,588 2023 126,545 32,919 2024 95,883 - 2025 82,029 - 2026 47,321 - Total 471,320 154,507 Less: Current maturities 119,542 121,588 Long-term liability $ 351,778 $ 32,919

Note 7 - Convertible notes rece

Note 7 - Convertible notes receivable3 Months Ended
Mar. 31, 2021
Notes
Note 7 - Convertible notes receivableNote 7 – Convertible notes receivable Convertible notes receivable consists of the following: March 31, 2021 December 31, 2020 November 22, 2017, NeuCourt, Inc. convertible note receivable including accrued interest of $1,774 and $1,454 at March 31, 2021 and December 31, 2020. The note bears interest at 5% per annum, originally matured November 22, 2019, and was extended to mature November 22, 2021. Principal and accrued interest are due at maturity. Upon extension, the Company received a cash payment of $2,496 for interest accrued through November 4, 2019. Principal and unpaid interest may be converted into a blend of shares of a to-be-created series of Preferred Stock and Common Stock of NeuCourt (i) on closing of a future financing round of at least $750,000, (ii) on the election of NeuCourt on maturity of the Note, or (iii) on election of Mentor following NeuCourt’s election to prepay the Note. * $ 26,774 $ 26,454 October 31, 2018, NeuCourt, Inc. convertible note receivable including accrued interest of $6,257 and $5,584 at March 31, 2021 and December 31, 2020. The note bears interest at 5% per annum and matures October 31, 2022. Principal and accrued interest are due at maturity. Principal and unpaid interest may be converted into a blend of shares of a to-be-created series of Preferred Stock and Common Stock of NeuCourt (i) on closing of a future financing round of at least $750,000, (ii) on the election of NeuCourt on the maturity of the Note, or (iii) on the election of Mentor following NeuCourt’s election to prepay the Note. * 56,257 55,584 Total convertible notes receivable 83,031 82,038 Less current portion (26,774) (26,454) Long term portion $ 56,257 $ 55,584 *

Note 8 - Finance leases receiva

Note 8 - Finance leases receivable3 Months Ended
Mar. 31, 2021
Notes
Note 8 - Finance leases receivableNote 8 – Finance leases receivable Partner II entered into a Master Equipment Lease Agreement with Pueblo West, dated February 11, 2018, amended November 28, 2018 and March 12, 2019. Partner II acquired and delivered manufacturing equipment as selected by Pueblo West under sales-type finance leases. Partner II did not record any sales revenue for the three months ended March 31, 2021 and 2020. At March 31, 2021, all Partner II leased equipment under finance leases receivable is located in Colorado. Performing net finance leases receivable consisted of the following: March 31, 2021 December 31, 2020 Gross minimum lease payments receivable $ 450,136 $ 477,680 Accrued interest 2,055 2,141 Less: unearned interest (94,539) (103,870) Finance leases receivable 357,652 375,951 Less current portion (70,896) (69,053) Long term portion $ 286,756 $ 306,898 Finance lease revenue recognized on Partner II finance leases for the three months ended March 31, 2021 and 2020 was $10,956 and $12,538, respectively. At March 31, 2021, minimum future payments receivable for performing finance leases receivable were as follows: 12 months ending March 31, Lease Receivable Interest 2022 $ 70,529 $ 39,646 2023 83,163 27,012 2024 92,048 18,127 2025 93,977 8,346 2026 14,664 1,295 Thereafter 1,216 113 $ 355,597 $ 94,539

Note 9 - Contractual interests

Note 9 - Contractual interests in legal recoveries3 Months Ended
Mar. 31, 2021
Notes
Note 9 - Contractual interests in legal recoveriesNote 9 - Contractual interests in legal recoveries Interest in Electrum Partners, LLC legal recovery Electrum is the plaintiff in that certain legal action captioned Electrum Partners, LLC, Plaintiff, and Aurora Cannabis Inc., Defendant, On October 30, 2018, Mentor entered into a Recovery Purchase Agreement (“Recovery Agreement”) with Electrum under which Mentor purchased a portion of Electrum’s potential recovery in the Litigation. Mentor agreed to pay $100,000 of costs incurred in the Litigation, in consideration for ten percent (10%) of anything of value received by Electrum as a result of the Litigation (“Recovery”) in addition to repayment of its initial investment. As of March 31, 2021 and December 31, 2020, Mentor invested an additional $81,529 and $81,529, respectively, of capital in Electrum for payment of legal retainers and fees in consideration for an additional eight percent (8%) of the Recovery. At March 31, 2021 and December 31, 2020, the Recovery Agreement investment is reported in the condensed consolidated balance sheets at our cost of $181,529 and $181,529, respectively. This investment is subject to loss should Electrum not prevail in the Litigation. However, Company management estimates that recovery is more likely than not, and no impairment has been recorded at March 31, 2019 and December 31, 2020. On October 31, 2018, Mentor also entered into a secured Capital Agreement with Electrum under which Mentor invested an additional $100,000 of capital in Electrum. In consideration for Mentor’s investment, Electrum shall pay to Mentor, on the payment date, the sum of (i) $100,000, (ii) ten percent of the Recovery, and (iii) 0.083334% of the Recovery for each full month from October 31, 2018 to the payment date for each full month that $833 is not paid to Mentor. The payment date under the October 31, 2018 Capital Agreement is the earlier of November 1, 2021, or the final resolution of the Litigation. Payment is secured by all assets of Electrum. This investment is included at cost of $100,000 in Contractual interests in legal recoveries on the condensed consolidated balance sheets at March 31, 2021 and December 31, 2020. On January 28, 2019, Mentor entered into a second secured Capital Agreement with Electrum. Under the second Capital Agreement, Mentor invested an additional $100,000 of capital in Electrum. In consideration for Mentor’s investment, Electrum shall pay to Mentor on the payment date the sum of (i) $100,000, (ii) ten percent (10%) of the Recovery, and (iii) the greater of (A) 0.083334% of the Recovery for each full month from the date hereof until the payment date if the Recovery occurs prior to the payment date, and (B) $833.34 for each full month from the date hereof until the payment date. The payment date is the earlier of November 1, 2021, and the final resolution of the Litigation. This investment is included at its $100,000 cost as part of the Contractual interests in legal recoveries on the condensed consolidated balance sheets at March 31, 2021 and December 31, 2020. In addition, the second Capital Agreement provides that Mentor may, at any time up to and including 90 days following the payment date, elect to convert its 6,198 membership interests in Electrum into a cash payment of $194,028 plus an additional 19.4% of the Recovery. Recovery on this claim has been delayed due to COVID-19. The Company’s interest in the Electrum Partners, LLC legal recovery, carried at cost, at March 31, 2021 and December 31, 2020 is summarized as follows: March 31, 2021 December 31, 2020 October 30, 2018 Recovery Purchase Agreement $ 181,529 $ 181,529 October 31, 2018 secured Capital Agreement 100,000 100,000 January 28, 2019 secured Capital Agreement 100,000 100,000 Total Invested $ 381,529 $ 381,529 The hierarchy of Level 1, Level 2 and Level 3 Assets are listed as following: Fair Value Measurement Using Unadjusted Quoted Market Prices Quoted Prices for Identical or Similar Assets in Active Markets Significant Unobservable Inputs Significant Unobservable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) (Level 3) (Level 3) Investment in Securities Contractual interest Legal Recovery Investment in Common Stock Warrants Other Equity Investments Balance at December 31, 2019 - - 346,195 5,669 204,028 Total gains or losses Included in earnings (or changes in net assets) (10,292) - - (4,669) - Purchases, issuances, sales, and settlements Purchases 83,536 - 50,717 - - Issuances - - - - - Sales (38,418) - - - - Settlements - - (15,383) - - Balance at December 31, 2020 $ 34,826 $ - $ 381,529 $ 1,000 $ 204,028 Total gains or losses Included in earnings (or changes in net assets) 4,850 - - - - Purchases, issuances, sales, and settlements Purchases - - - - - Issuances - - - - - Sales - - - - - Settlements - - - - - Balance at March 31, 2021 $ 39,676 $ - $ 381,529 $ 1,000 $ 204,028 The amortized costs, gross unrealized holding gains and losses, and fair values of the Company’s investment securities classified as equity securities, at fair value, at March 31, 2021 consists of the following: Type Amortized Costs Gross Unrealized Gains Gross Unrealized Losses Fair Values NYSE listed company stock $ 10,080 $ (1,167) $ - $ 8,913 NASDAQ listed company stock 35,341 (4,578) - 30,763 $ 45,421 $ (5,745) $ - $ 39,676 The portion of unrealized gains and losses for the period related to equity securities still held at the reporting date is calculated as follows: Three Months Ended March 31, 2021 2020 Net gains and losses recognized during the period on equity securities $ 4,849 $ (5,037) Less: Net gains (losses) recognized during the period on equity securities sold during the period - - Unrealized gains and losses recognized during the reporting period on equity securities still held at the reporting date $ 4,849 $ (5,037)

Note 11 - Common stock warrants

Note 11 - Common stock warrants3 Months Ended
Mar. 31, 2021
Notes
Note 11 - Common stock warrantsNote 11 - Common stock warrants On August 21, 1998, the Company filed for voluntary reorganization with the United States Bankruptcy Court for the Northern District of California, and on January 11, 2000, the Company’s Plan of Reorganization was approved. Among other things, the Company’s Plan of Reorganization allowed creditors and claimants to receive new Series A, B, C, and D warrants in settlement of their prior claims. The warrants expire on May 11, 2038. All Series A, B, C, and D warrants have been called, and all Series A and C warrants have been exercised. The Company intends to allow warrant holders or Company designees, in place of original holders, additional time as needed to exercise the remaining series B and D warrants. The Company may lower the exercise price of all or part of a warrant series at any time. Similarly, the Company could reverse split the stock to raise the stock price above the warrant exercise price. The warrants are specifically not affected and do not split with the shares in the event of a reverse split. If the called warrants are not exercised, the Company has the right to designate the warrants to a new holder in return for a $0.10 per share redemption fee payable to the original warrant holders. All such changes in the exercise price of warrants were provided for by the court in the Plan of Reorganization to provide a mechanism for all debtors to receive value even if they could not or did not exercise their warrant. Therefore, Management believes that the act of lowering the exercise price is not a change from the original warrant grants and the Company did not record an accounting impact as the result of such change in exercise prices. All Series A and Series C warrants were exercised by December 31, 2014. Exercise prices in effect at January 1, 2015 through March 31, 2021 for Series B warrants were $0.11 and Series D warrants were $1.60. In 2009, the Company entered into an Investment Banking agreement with Network 1 Financial Securities, Inc. and a related Strategic Advisory Agreement with Lenox Hill Partners, LLC with regard to a potential merger with a cancer development company. In conjunction with those related agreements, the Company issued 689,159 Series H ($7) Warrants, with a 30-year life. The warrants are subject to cashless exercise based upon the ten-day trailing closing bid price preceding the exercise as interpreted by the Company. As of March 31, 2021 and December 31, 2020, the weighted average contractual life for all Mentor warrants was 17.3 years and 17.5 years, respectively, and the weighted average outstanding warrant exercise price was $2.11 and $2.11 per share, respectively. During the three months ended March 31, 2021 and 2020, there were no warrants exercised and there were no warrants issued. The intrinsic value of outstanding warrants at March 31, 2021 and December 31, 2020 was $5,247 and $0, respectively. The following table summarizes Series B and Series D common stock warrants as of each period: Series B Series D B and D Total Outstanding at December 31, 2019 87,456 6,252,954 6,340,410 Issued - - - Exercised - - - Outstanding at December 31, 2020 87,456 6,252,954 6,340,410 Issued - - - Exercised - - - Outstanding at March 31, 2021 87,456 6,252,954 6,340,410 Series E, F, G, and H warrants were issued for investment banking and advisory services during 2009. Series E, F, and G warrants were exercised in 2014. The following table summarizes Series H ($7) warrants as of each period: Series H $7.00 exercise price Outstanding at December 31, 2019 689,159 Issued - Exercised - Outstanding at December 31, 2020 689,159 Issued - Exercised - Outstanding at March 31, 2021 689,159 On February 9, 2015, in accordance with Section 1145 of the United States Bankruptcy Code and the Company’s Plan of Reorganization, the Company announced a minimum 30-day partial redemption of up to 1% (approximately 90,000) of the already outstanding Series D warrants to provide for the court specified redemption mechanism for warrants not exercised timely by the original holder or their estates. Company designees that applied during the 30 days paid 10 cents per warrant to redeem the warrant and then exercised the Series D warrant to purchase a share at the court specified formula of not more than one-half of the closing bid price on the day preceding the 30-day exercise period. In the Company’s October 7, 2016 press release, Mentor stated that the 1% redemptions which were formerly priced on a calendar month schedule would subsequently be initiated and be priced on a random date to be scheduled after the prior 1% redemption is completed to prevent potential third-party manipulation of share prices at month-end. The periodic partial redemptions will continue to be periodically recalculated and repeated until such unexercised warrants are exhausted, or the partial redemption is otherwise paused, suspended or truncated by the Company. For the three months ended March 31, 2021 and 2020, no warrants were redeemed.

Note 12 - Warrant redemption li

Note 12 - Warrant redemption liability3 Months Ended
Mar. 31, 2021
Notes
Note 12 - Warrant redemption liabilityNote 12 - Warrant redemption liability The Plan of Reorganization provides the right for the Company to call, and the Company or its designee to redeem warrants that are not exercised timely, as specified in the Plan, by transferring a $0.10 redemption fee to the former holders. Certain individuals desiring to become a Company designee to redeem warrants have deposited redemption fees with the Company that, when warrants are redeemed, will be forwarded to the former warrant holders through DTCC or at their last known address 30 days after the last warrant of a class is exercised, or earlier at the discretion of the Company. The Company has arranged for a service to process the redemption fees in offset to an equal amount of liability. In prior years the Series A, Series B, and Series C redemption fees have been distributed through DTCC into holder’s brokerage accounts or directly to the holders. All Series A and Series C warrants have been exercised and are no longer outstanding. There are 87,456 Series B warrants outstanding which are held by Chet Billingsley, the Company’s Chief Executive Officer (“CEO”). Once the Series D warrants have been fully redeemed and exercised, the fees for the Series D warrant series will likewise be distributed. Mr. Billingsley has agreed to assume liability for paying these redemption fees and therefore warrant redemption fees received are retained by the Company for operating costs. Should Mr. Billingsley be incapacitated or otherwise become unable to pay the warrant redemption fees, the Company will remit the warrant redemption fees to former holders from amounts due to Mr. Billingsley from the Company, which are sufficient to cover the redemption fees at March 31, 2021 and December 31, 2020.

Note 13 - Stockholders' equity

Note 13 - Stockholders' equity3 Months Ended
Mar. 31, 2021
Notes
Note 13 - Stockholders' equityNote 13 - Stockholders’ equity Common Stock The Company was incorporated in California in 1994 and was redomiciled as a Delaware corporation, effective September 24, 2015. There are 75,000,000 authorized shares of Common Stock at $0.0001 par value. The holders of Common Stock are entitled to one vote per share on all matters submitted to a vote of the stockholders. On August 8, 2014, the Company announced that it was initiating the repurchase of 300,000 shares of its Common Stock (approximately 2% of the Company’s common shares outstanding at that time). As of March 31, 2021 and December 31, 2020, 44,748 and 44,748 shares have been repurchased and retired, respectively. Preferred Stock Mentor has 5,000,000, $0.0001 par value, preferred shares authorized. On July 13, 2017, the Company filed a Certificate of Designation of Rights, Preferences, Privileges and Restrictions of Series Q Preferred Stock (“Certificate of Designation”) with the Delaware Secretary of State to designate 200,000 preferred shares as Series Q Preferred Stock, such series having a par value of $0.0001 per share. Series Q Preferred Stock is convertible into Common Stock, at the option of the holder, at any time after the date of issuance of such share and prior to notice of redemption of such share of Series Q Preferred Stock by the Company, into such number of fully paid and nonassessable shares of Common Stock as determined by dividing the Series Q Conversion Value by the Conversion Price at the time in effect for such share. The per share “Series Q Conversion Value,” as defined in the Certificate of Designation, shall be calculated by the Company at least once each calendar quarter as follows: The per share Series Q Conversion Value shall be equal to the quotient of the “Core Q Holdings Asset Value” divided by the number of issued and outstanding shares of Series Q Preferred Stock. The “Core Q Holdings Asset Value” shall equal the value, as calculated and published by the Company, of all assets that constitute Core Q Holdings which shall include such considerations as the Company designates and need not accord with any established or commonly employed valuation method or considerations. “Core Q Holdings” consists of all proceeds received by the Company on the sale of shares of Series Q Preferred Stock and all securities, acquisitions, and business acquired from such proceeds by the Company. The Company shall periodically, but at least once each calendar quarter, identify, update, account for and value, the assets that comprise the Core Q Holdings. The “Conversion Price” of the Series Q Preferred Stock shall be at the product of 105% and the closing price of the Company’s Common Stock on a date designated and published by the Company. The Series Q Preferred Stock is intended to allow for a pure play investment in cannabis companies that have the potential to go public. The Series Q Preferred Stock will be available only to accredited, institutional or qualified investors. The Company sold and issued 11 shares of Series Q Preferred Stock on May 30, 2018, at a price of $10,000 per share, for an aggregate purchase price of $110,000 (“Series Q Purchase Price”). The Company invested the Series Q Purchase Price as capital in Partner II to purchase equipment to be leased to Pueblo West. Therefore, the Core Q Holdings at March 31, 2021 and December 31, 2020 include this interest. The Core Q Holdings Asset Value at March 31, 2021 and December 31, 2020 was $16,670 and $16,207 per share, respectively. There is no contingent liability for the Series Q Preferred Stock conversion at March 31, 2021 and December 31, 2020. At March 31, 2021 and December 31, 2020, the Series Q Preferred Stock could have been converted at the Conversion Price of $0.173 and $0.085, respectively, into an aggregate of 1,059,969 and 2,097,358 shares of the Company’s Common Stock, respectively. Because there were net losses for the three month periods ended March 31, 2021 and 2020, these shares were anti-dilutive and therefore are not included in the weighted average share calculation for these periods.

Note 14 - Term Loan

Note 14 - Term Loan3 Months Ended
Mar. 31, 2021
Notes
Note 14 - Term LoanNote 14 - Term Loan Term debt as of March 31, 2021 and December 31, 2020 consists of the following: March 31, 2021 December 31, 2020 Bank of America auto loan, interest at 2.37% per annum, monthly principal and interest payments of $1,448, maturing December 2025, collateralized by vehicle. 77,983 $ 81,812 Less: Current maturities (15,696) (15,566) $ 62,287 $ 66,246

Note 15 - Paycheck Protection P

Note 15 - Paycheck Protection Plan Loans and Economic Injury Disaster Loans3 Months Ended
Mar. 31, 2021
Notes
Note 15 - Paycheck Protection Plan Loans and Economic Injury Disaster LoansNote 15 – Paycheck Protection Plan Loans and Economic Injury Disaster Loans Paycheck protection plan loans In 2020, the Company and WCI each received loans in the amount of $76,500 and $383,342, respectively, from the Bank of Southern California and the Republic Bank of Arizona (collectively, the “PPP Loans”). The PPP Loans were forgiven in November 2020, except for $10,000 of WCI’s loan that was not eligible for forgiveness due to receipt of a $10,000 Economic Injury Disaster Loan Advance (“EIDL Advance”). However, on December 27, 2020, Section 1110(e)(6) of the CARES Act was repealed by Section 333 of the Economic Aid Act. As a result, the SBA automatically remitted a reconciliation payment to WCI’s PPP lender, the Republic Bank of Arizona, for the previously-deducted EIDL Advance amount, plus interest through the remittance date. On March 16, 2021, The Republic Bank of Arizona notified WCI of receipt of the reconciliation payment and full forgiveness of the EIDL Advance. The $10,000 forgiveness is reflected as other income for the three months ended March 31, 2021, in the condensed consolidated income statements. On February 17, 2021, Mentor received a second PPP Loan in the amount of $76,593 (“Second PPP Loan) pursuant to Division N, Title III, of the Consolidated Appropriations Act, 2021 (the “Economic Aid Act”) as further set forth at Section 311 et. seq. The Second PPP Loan is forgivable so long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent, utilities, and other covered operations expenditures, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the forgiveness period. The Company records PPP Loans as a liability in accordance with FASB ASC 470, “Debt” and records accrued interest through the effective date of forgiveness on the PPP Loans. Total gain on extinguishment of the PPP Loans and accrued interest is reported in other income and expense in the consolidated income statement. PPP loan balances consist of the following: March 31, 2021 December 31, 2020 May 5, 2020, PPP loan from Republic Bank of Arizona to Waste Consolidators, Inc., revised December 1, 2020. The note bears interest at 1% per annum, with a revised maturation date of May 15, 2020, with monthly principal and interest payments of $560 beginning December 15, 2020. On March 16, 2021, WCI was notified of full forgiveness of the note. $ - $ 9,449 February 17, 2021, Second PPP loan from the Bank of Southern California, with accrued interest of $88 at March 31, 2021. The loan bears interest at 1% per annum and matures January 16, 2026. Mentor may apply for forgiveness for amounts disbursed for covered costs. Payment on any unforgiven amount begins within ten months after last day of the loan forgiveness covered period (i) beginning on the date that is 8 weeks after the date of disbursement and (ii) ending on the date that is 24 weeks after the date of disbursement. 76,681 - Total 76,681 9,449 Less: Current maturities - (6,658) Long-term portion of paycheck protection plan loans $ 76,681 $ 2,791 Interest expense on PPP Loans for the three months ended March 31, 2021 and 2020 was $88 and $0, respectively. Economic injury disaster loan On July 9, 2020, WCI received an additional Economic Injury Disaster Loan in the amount of $150,000 through the SBA. The loan is secured by all tangible and intangible personal property of WCI, bears interest at 3.75% per annum, requires monthly installment payments of $731 beginning July 2020, and matures July 2050. The loan is collateralized by all tangible and intangible assets of WCI. EIDL loan balances at March 31, 2021 consist of the following: March 31, 2021 December 31, 2020 July 9, 2020, WCI received an additional Economic Injury Disaster Loan, including accrued interest of $4,093 and $2,502 as of March 31, 2021 and December 31, 2020, respectively. The note is secured by all tangible and intangible personal property of WCI, bears interest at 3.75% per annum, requires monthly installment payments of $731 beginning July 2021, and matures July 2050. $ $ 153,993 $ 152,602 Less: Current maturities - - Long-term portion of economic injury disaster loan $ $ 153,993 $ 152,602 Interest expense on the EIDL Loan for the three months ended March 31, 2021 and 2020 was $1,392 and $0, respectively.

Note 16 - Accrued salary, accru

Note 16 - Accrued salary, accrued retirement, and incentive fee - related party3 Months Ended
Mar. 31, 2021
Notes
Note 16 - Accrued salary, accrued retirement, and incentive fee - related partyNote 16 - Accrued salary, accrued retirement, and incentive fee - related party The Company had an outstanding liability to its CEO as follows: March 31, 2021 December 31, 2020 Accrued salaries and benefits $ 856,784 $ 848,796 Accrued retirement and other benefits 510,538 550,191 Offset by shareholder advance (261,653) (261,653) $ 1,105,669 $ 1,137,334 As approved by resolution of the Board of Directors in 1998, the CEO will be paid an incentive fee and a bonus which are payable in installments at the CEO’s option. The incentive fee is 1% of the increase in market capitalization based on the bid price of the Company’s stock beyond the book value at confirmation of the bankruptcy, which was approximately $260,000. The bonus is 0.5% of the increase in market capitalization for each $1 increase in stock price up to a maximum of $8 per share (4%) based on the bid price of the stock beyond the book value at confirmation of the bankruptcy. For the three months ended March 31, 2021 and 2020, the incentive fee expense was $0 and $0, respectively.

Note 17 - Related party transac

Note 17 - Related party transactions3 Months Ended
Mar. 31, 2021
Notes
Note 17 - Related party transactionsNote 17 – Related party transactions On December 15, 2020, WCI received a $20,000 short term loan from an officer of WCI, which is reflected as a related party payable at March 31, 2021 and December 31, 2020. On March 12, 2021, Mentor received a $100,000 loan from its CEO, which bears interest at 7.8% per annum compounded quarterly and is due upon demand. The loan from the related party and accrued interest of $196 is reflected as a long-term liability at March 31, 2021. For the three months ended March 31, 2021, the interest expense on the long-term loan from the related party was $196.

Note 18 - Commitments and conti

Note 18 - Commitments and contingencies3 Months Ended
Mar. 31, 2021
Notes
Note 18 - Commitments and contingenciesNote 18 – Commitments and contingencies G FarmaLabs Limited, a Nevada corporation (“G Farma”) has not made scheduled payments on the finance lease receivable or the notes receivable summarized below since February 19, 2019. All amounts due from G Farma are fully impaired at March 31, 2021 and December 31, 2020. A complete description of the agreements can be found in the Company’s Annual Report for the period ended December 31, 2020 on Form 10-K as filed with the SEC on April 15, 2021. On March 17, 2017, the Company entered into a Notes Purchase Agreement with G Farma, with operations in Washington that had planned operations in California under two temporary licenses pending completion of its Desert Hot Springs, California, location. Under the Agreement, the Company purchased two secured promissory notes from G Farma in an aggregate principal face amount of $500,000. Subsequent to the initial investment, the Company executed eight addenda. Addendum II through Addendum VIII increased the aggregate principal face amount of the two notes to $1,100,000 and increased the combined monthly payments of the notes to $10,239 per month beginning March 15, 2019 with a balloon payment on the notes of approximately $894,172 due at maturity. On September 6, 2018, the Company entered into an Equity Purchase and Issuance Agreement with G FarmaLabs Limited, G FarmaLabs DHS, LLC, GFBrands, Inc., Finka Distribution, Inc., and G FarmaLabs, WA, LLC under which Mentor was supposed to receive equity interests in the G Farma Equity Entities and their affiliates (together, the “G Farma Equity Entities”) equal to 3.75% of the G Farma Equity Entities’ interests. On March 4, 2019, Addendum VIII increased the G Farma Equity Entities’ equity interest to which Mentor is immediately entitled to 3.843%, and added Goya Ventures, LLC as a G Farma Equity Entity. We are now in litigation with these entities;the equity investment was fully impaired at March 31, 2021 and December 31, 2020. Partner I acquired and delivered manufacturing equipment as selected by the G Farma Entities under sales-type finance leases. The finance leases resulting from this investment have been fully impaired at March 31, 2021 and December 31, 2020. On May 28, 2019, the Company and Mentor Partner I, LLC filed suit against the G Farma Entities and three guarantors to the G Farma agreements, summarized above, in the California Superior Court in and for the County of Marin. The Company is primarily seeking monetary damages for breach of the G Farma agreements, including promissory notes, leases, and other agreements, to recover collateral under a security agreement and to collect from guarantors on the agreements. The Company previously sought, and on January 22, 2020, the Court granted the Company’s request for a writ of possession to recover leased equipment within G Farma’s possession. On November 4, 2020, the Court granted Mentor Capital, Inc.’s and Mentor Partner I’s motion for summary adjudication as to all four causes of action, including both causes of action against G FarmaLabs Limited for liability for breach of the two promissory notes and one cause of action against each of Mr. Gonzalez and Ms. Gonzalez related to their duties as guarantors of G FarmaLabs Limited’s obligations under the promissory notes. On November 13, 2019, G Farma filed a Cross-Complaint for declaratory relief and breach of contract relating to the consulting agreement between Mentor and G Farma. The Company filed an answer on December 6, 2019, denying each and every allegation of the Cross-Complaint and intends to vigorously defend itself in this matter. Mentor is currently in the process of preparing for trial on the remaining causes of action against the G Farma Entities and their guarantors. The Company also plans to vigorously pursue its remaining claims against the G Farma Entities; however, collection is uncertain at this time. Due to uncertainty of collection, the Company has fully reserved against the finance leases receivable (more fully described in the Company’s Annual Report for the period ended December 31, 2020 on Form 10-K, Footnote 8, as filed with the SEC April 15, 2021) and has fully impaired all other notes receivables and investments in G Farma (described in the Company’s Annual Report for the period ended December 31, 2020 on Form 10-K, Footnotes 7, 9 and 10. On January 31, 2020, as authorized by court order, all remaining equipment leased to G Farma by Mentor Partner I was repossessed by the Company and moved to storage under the Company’s control. In the quarter ended March 31, 2020, the Company sold a portion of the recovered equipment, with an original cost of $495,967, for net proceeds of $222,031. In the quarter ended June 30, 2020, the Company sold all remaining recovered equipment, with an original cost of $126,703, for net proceeds of $27,450, after deducting shipping and delivery costs. All proceeds from the sale of repossessed equipment have been applied to the G Farma lease receivable balance that is fully reserved at March 31, 2021 and December 30, 2020. The Company will continue to legally pursue award and collection of damages in the amount of $1,166,570.62 related to the G Farma promissory notes from the G Farma Entities and three guarantors. The Company and Partner I will continue to pursue the the remaining causes of action in the litigation and award and collection of the $1,290,174 lease payments remaining from the G Farma Lease Entities and the G Farma guarantors after applying proceeds from the sale of Partner I’s recovered equipment assets.

Note 19 - Segment Information

Note 19 - Segment Information3 Months Ended
Mar. 31, 2021
Notes
Note 19 - Segment InformationNote 19 – Segment Information The Company is an operating, acquisition, and investment business. Subsidiaries in which the Company has a controlling financial interest are consolidated. The Company generally has two reportable segments; 1) the cannabis and medical marijuana segment, which includes the cost basis of membership interests of Electrum, the contractual interest in the Electrum legal recovery, and the operation of subsidiaries in the cannabis and medical marijuana sector; and 2) the Company’s long standing investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their facility-related operating costs. The Company also had small investments in securities listed on the NYSE and NASDAQ, an investment in note receivable from a non-affiliated party, the fair value of convertible notes receivable and accrued interest from NeuCourt, and the investment in NeuCourt that is included in the Corporate, Other, and Eliminations section below. The NeuCourt investments were previously reported as an investment that would be useful in the cannabis space; however, NeuCourt has determined that its legal services would likely be more useful to users outside of the cannabis space. Prior period segment information presented below contains reclassification of NeuCourt investments from the cannabis and medical marijuana segment to the Corporate, other, and eliminations segment. Cannabis and Medical Marijuana Segment Facility Operations Related Corporate, Other and Eliminations Consolidated Three months ended March 31, 2021 Net revenue $ 10,871 $ 1,309,753 $ - $ 1,320,624 Operating income (loss) 6,125 (3,946) (166,922) (164,743) Interest income - - 16,489 16,489 Interest expense - 8,498 3,572 12,070 Property additions - 6,595 1,264 7,859 Depreciation and amortization - 7,960 1,461 9,421 Total assets 1,005,990 2,124,769 1,644,546 4,775,305 Three months ended March 31, 2020 Net revenue $ 12,538 $ 1,136,924 $ - $ 1,149,462 Operating income (loss) (8,905) 34,176 (261,994) (236,723) Interest income 24 - 19,379 19,403 Interest expense - 8,471 (1,134) 7,337 Property additions - 3,329 - 3,329 Depreciation and amortization - 2,640 1,202 3,842 Total assets 2,343,236 1,657,984 764,633 4,765,853 The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements: Three Months Ended March 31, 2021 2020 Operating loss $ (164,743) $ (236,723) Gain (loss) on investments in securities 4,849 (5,037) Gain (loss) on long-term investments - (5,169) Paycheck Protection Program Loan forgiveness 10,000 - Interest income 16,849 19,403 Interest expense (12,070) (7,337) Loss on ROU asset disposal (643) - Other income (expense) (1,053) 12,084 Income before income taxes $ (147,171) $ (222,779)

Note 20 - Subsequent events

Note 20 - Subsequent events3 Months Ended
Mar. 31, 2021
Notes
Note 20 - Subsequent eventsNote 20 – Subsequent events Effective upon filing this Form 10-Q, Lori Stansfield will no longer serve as the Company’s Chief Financial Officer. The transition between Ms. Stansfield, a California resident, and the Company, now relocated to Plano, Texas, is amicable, and there are no accounting disagreements. As needed, Ms. Stansfield will continue to provide transition support to the Company to assist with its reporting obligations. Ms. Stansfield will remain a Director and the Treasurer of the Company’s board of directors. Ms. Stansfield continues to be a significant shareholder of the Company. Because of his employer's acquisition by a prominent public company, effective May 15, 2021, Stan Shaul will no longer be able to serve as a board member and audit committee member of Mentor Capital or any other public company. Mr. Shaul expressed that it was a pleasure to serve as a Director of the Company for over twenty years, since his appointment to the board on November 24, 1998. Mr. Shaul remains a significant shareholder of the Company.

Note 2 - Summary of significa_2

Note 2 - Summary of significant accounting policies: Condensed consolidated financial statements (Policies)3 Months Ended
Mar. 31, 2021
Policies
Condensed consolidated financial statementsCondensed consolidated financial statements The unaudited condensed consolidated financial statements of the Company for the three month period ended March 31, 2021 and 2020 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-K. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of December 31, 2020 was derived from the audited financial statements included in the Company's financial statements as of and for the year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on April 15, 2021. These financial statements should be read in conjunction with that report.

Note 2 - Summary of significa_3

Note 2 - Summary of significant accounting policies: Basis of presentation (Policies)3 Months Ended
Mar. 31, 2021
Policies
Basis of presentationBasis of presentation The accompanying consolidated financial statements and related notes include the activity of subsidiaries in which a controlling financial interest is owned. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Significant intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform with the current period presentation. As shown in the accompanying financial statements, the Company has a significant accumulated deficit of $10,748,154 as of March 31, 2021. The Company continues to experience negative cash flows from operations. The Company management believes it is more likely than not that Electrum will prevail in the legal action described in Note 9 to the consolidated financial statements, in which the Company has an interest. However, there is no surety that Electrum will prevail in its legal action or that we will be able to recover our funds and our percentage of the Litigation Recovery if Electrum does prevail. The Company will be required to raise additional capital to fund its operations and will continue to attempt to raise capital resources from both related and unrelated parties until such time as the Company is able to generate revenues sufficient to maintain itself as a viable entity. These factors have raised substantial doubt about the Company's ability to continue as a going concern. These financial statements are presented on the basis that we will continue as a going concern. The going concern concept contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. There can be no assurances that the Company will be able to raise additional capital or achieve profitability. However, the Company has approximately 6.2 million warrants outstanding in which the Company can reset the exercise price substantially below the current market price. These condensed consolidated financial statements do not include any adjustments that might result from repricing the outstanding warrants. Management's plans include increasing revenues through acquisition, investment, and organic growth. Management anticipates funding these activities by raising additional capital through the sale of equity securities and debt.

Note 2 - Summary of significa_4

Note 2 - Summary of significant accounting policies: Impact Related to COVID-19 (Policies)3 Months Ended
Mar. 31, 2021
Policies
Impact Related to COVID-19Impact Related to COVID-19 The effect of the novel coronavirus (“COVID-19”) has significantly impacted the United States and the global economy. COVID-19 and the measures taken by many countries in response have adversely affected and could in the future materially adversely impact the Company’s business, results of operations, financial condition, and stock price. As of March 31, 2021, the impact of COVID-19 continues to unfold. The ongoing worldwide economic situation, future weakness in the credit markets, and significant liquidity problems for the financial services industry may impact our financial condition in a number of ways. For example, our current or potential customers, or the current or potential customers of our partners or affiliates, may delay or decrease spending with us, or may not pay us, or may delay paying us for previously purchased products and services. Also, we, or our partners or affiliates, may have difficulties in securing additional financing. Our legal recovery efforts have been hindered and may continue to be constrained, due to the closure of the courts in California and British Columbia, which may cause COVID-19-related scheduling delays, hindering our legal recovery from the G Farma Entities and delaying the receipt of the Company’s interest in the Electrum Partners, LLC legal recovery, respectively. Additionally, the collectability of our investment in accounts receivable has been impaired by $139,148 in the fourth quarter of 2020, due to a reduction in our expected collection amount of the 2020 and 2021 payments of an installment contract, see Note 4. Public health efforts to mitigate the impact of COVID-19 have included government actions such as travel restrictions, limitations on public gatherings, shelter in place orders, and mandatory closures. These actions are being lifted to varying degrees. WCI has not experienced an overall reduced demand for services initially anticipated because WCI helps lower monthly service costs paid by its client properties. However, WCI’s clients may experience a delay in collecting rent from tenants, which may cause slower payments to WCI. WCI closely monitors customer accounts and has not experienced significant delays in the collection of accounts receivable. According to the Critical Infrastructure Standards released by the Cybersecurity and Infrastructure Security Agency on March 18, 2020, “Financial Services Sector” businesses, like Mentor, are considered “essential businesses.” Because of the financial nature of Mentor’s operations, which consist of oversight of our portfolio companies, accounting, compliance, investor relations, and sales, Mentor’s day-to-day operations are not substantially hindered by remote office work or telework. We anticipate that current cash resources will be sufficient for us to execute our business plan for the next 9 months. The ultimate impact of COVID-19 on our business, results of operations, financial condition and cash flows is dependent on future developments, including the duration of COVID-19 and the related length of its impact on the global economy, which are uncertain and cannot be predicted at this time.

Note 2 - Summary of significa_5

Note 2 - Summary of significant accounting policies: Use of estimates (Policies)3 Months Ended
Mar. 31, 2021
Policies
Use of estimatesUse of estimates The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and judgments that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of our consolidated financial statements, and the reported amount of revenues and expenses during the reporting period. Significant estimates relied upon in preparing these consolidated financial statements include revenue recognition, accounts and notes receivable reserves, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to investments, goodwill, amortization periods, accrued expenses, and recoverability of the Company’s net deferred tax assets and any related valuation allowance. Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate.

Note 2 - Summary of significa_6

Note 2 - Summary of significant accounting policies: Recent Accounting Standards (Policies)3 Months Ended
Mar. 31, 2021
Policies
Recent Accounting StandardsRecent Accounting Standards From time to time, the FASB or other standards setting bodies issue new accounting pronouncements. Updates to the FASB Accounting Standard Codifications (“ASCs”) are communicated through the issuance of an Accounting Standards Update (“ASU”). Unless otherwise discussed, we believe that the impact of recently issued guidance, whether adopted or to be adopted in the future, is not expected to have a material impact on our consolidated financial statements upon adoption. There were no accounting pronouncements issued during the three months ended March 31, 2021 that are expected to have a material impact on the Company’s condensed consolidated financial statements.

Note 2 - Summary of significa_7

Note 2 - Summary of significant accounting policies: Concentrations of cash (Policies)3 Months Ended
Mar. 31, 2021
Policies
Concentrations of cashConcentrations of cash The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits. The Company has not experienced any losses in such accounts, nor does the Company believe it is exposed to any significant credit risk on cash and cash equivalents.

Note 2 - Summary of significa_8

Note 2 - Summary of significant accounting policies: Cash and cash equivalents (Policies)3 Months Ended
Mar. 31, 2021
Policies
Cash and cash equivalentsCash and cash equivalents The Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents. The Company had no short-term debt securities as of March 31, 2021 and December 31, 2020.

Note 2 - Summary of significa_9

Note 2 - Summary of significant accounting policies: Accounts receivable (Policies)3 Months Ended
Mar. 31, 2021
Policies
Accounts receivableAccounts receivable Accounts receivables consist of trade accounts arising in the normal course of business and are classified as current assets and carried at original invoice amounts less an estimate for doubtful receivables based on historical losses as a percent of revenue in conjunction with a review of outstanding balances on a quarterly basis. The estimate of the allowance for doubtful accounts is based on the Company's bad debt experience, market conditions, and aging of accounts receivable, among other factors. If the financial condition of the Company's customers deteriorates, resulting in the customer's inability to pay the Company's receivables as they come due, additional allowances for doubtful accounts will be required. At March 31, 2021 and December 31, 2020, the Company has an allowance for doubtful receivables in the amount of $65,631 and $59,461, respectively.

Note 2 - Summary of signific_10

Note 2 - Summary of significant accounting policies: Investments in securities at fair value (Policies)3 Months Ended
Mar. 31, 2021
Policies
Investments in securities at fair valueInvestments in securities at fair value Investment in securities consists of debt and equity securities reported at fair value. Under ASU 2016-01, “ Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities

Note 2 - Summary of signific_11

Note 2 - Summary of significant accounting policies: Long term investments (Policies)3 Months Ended
Mar. 31, 2021
Policies
Long term investmentsLong term investments The Company’s investments in entities where it is a minority owner and does not have the ability to exercise significant influence are recorded at fair value if readily determinable. If the fair market value is not readily determinable, the investment is recorded under the cost method. Under this method, the Company’s share of the earnings or losses of such investee company is not included in the Company’s financial statements. The Company reviews the carrying value of its long-term investments for impairment each reporting period.

Note 2 - Summary of signific_12

Note 2 - Summary of significant accounting policies: Investments in debt securities (Policies)3 Months Ended
Mar. 31, 2021
Policies
Investments in debt securitiesInvestments in debt securities The Company’s investment in debt securities consists of two convertible notes receivable from NeuCourt, Inc., which are recorded at the aggregate principal face amount of $75,000 plus accrued interest of $8,031 and $7,038 at March 31, 2021 and December 31, 2020, respectively, as presented in Note 7.

Note 2 - Summary of signific_13

Note 2 - Summary of significant accounting policies: Investment in account receivable, net of discount (Policies)3 Months Ended
Mar. 31, 2021
Policies
Investment in account receivable, net of discountInvestment in account receivable, net of discount The Company’s investment in account receivable is stated at face value, net of unamortized purchase discount. The discount is amortized to interest income over the term of the exchange agreement. In the fourth quarter of 2020, we were notified that due to the effect of COVID-19 on the estimated receivable, we may not receive the 2020 installment payment or the full 2021 installment payment. At March 31, 2021 and December 31, 2020, the Company has an impairment of the investment in account receivable of $139,148 and $139,148, respectively.

Note 2 - Summary of signific_14

Note 2 - Summary of significant accounting policies: Credit quality of notes receivable and finance leases receivable, and credit loss reserve (Policies)3 Months Ended
Mar. 31, 2021
Policies
Credit quality of notes receivable and finance leases receivable, and credit loss reserveCredit quality of notes receivable and finance leases receivable, and credit loss reserve As our notes receivable and finance leases receivable are limited in number, our management is able to analyze estimated credit loss reserves based on a detailed analysis of each receivable as opposed to using portfolio-based metrics. Our management does not use a system of assigning internal risk ratings to each of our receivables. Rather, each note receivable and finance lease receivable is analyzed quarterly and categorized as either performing or non-performing based on certain factors including, but not limited to, financial results, satisfying scheduled payments, and compliance with financial covenants. A note receivable or finance lease receivable will be categorized as non-performing when a borrower experiences financial difficulty and has failed to make scheduled payments. As part of the monitoring process, we may physically inspect the collateral or a borrower’s facility and meet with a borrower’s management to better understand such borrower’s financial performance and its future plans on an as-needed basis.

Note 2 - Summary of signific_15

Note 2 - Summary of significant accounting policies: Lessee Leases (Policies)3 Months Ended
Mar. 31, 2021
Policies
Lessee LeasesLessee Leases We determine whether an arrangement is a lease at inception. Lessee leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria is met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that is reasonably certain to be exercised, and (iii) the lease term is for a significant part of the remaining useful life of the asset or the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of these criteria. Our operating leases are comprised of office space leases and office equipment. Fleet vehicle leases entered into prior to January 1, 2019, are classified as operating leases based on an expected lease term of four years. Fleet vehicle leases entered into beginning January 1, 2019, for which the lease is expected to be extended to five years, are classified as finance leases. Our leases have remaining lease terms of one to forty-eight months. Our fleet finance leases contain a residual value guarantee which, based on past lease experience, is unlikely to result in a liability at the end of the lease. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Costs associated with operating lease assets are recognized on a straight-line basis, over the term of the lease, within cost of goods sold for vehicles used in direct servicing of WCI customers and in operating expenses for costs associated with all other operating leases. Finance lease assets are amortized within cost of goods sold for vehicles used in direct servicing of WCI customers and within operating expenses for all other finance lease assets, on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease term. The interest component of a finance lease is included in interest expense and recognized using the effective interest method over the lease term. We have agreements that contain both lease and non-lease components. For vehicle fleet operating leases, we account for lease components together with non-lease components (e.g., maintenance fees).

Note 2 - Summary of signific_16

Note 2 - Summary of significant accounting policies: Property, and equipment (Policies)3 Months Ended
Mar. 31, 2021
Policies
Property, and equipmentProperty, and equipment Property and equipment is recorded at cost less accumulated depreciation. Depreciation is computed on the declining balance method over the estimated useful lives of various classes of property. The estimated lives of the property and equipment are generally as follows: computer equipment, three to five years; furniture and equipment, seven years; and vehicles and trailers, four to five years. Depreciation on vehicles used by WCI to service its customers is included in cost of goods sold in the consolidated income statements. All other depreciation is included in selling, general and administrative costs in the consolidated income statements. Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property and equipment may not be recoverable in accordance with the provisions of ASC 360, “Property, Plant, and Equipment.” The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified.

Note 2 - Summary of signific_17

Note 2 - Summary of significant accounting policies: Goodwill (Policies)3 Months Ended
Mar. 31, 2021
Policies
GoodwillGoodwill Goodwill of $1,324,142 was derived from consolidating WCI effective January 1, 2014, and $102,040 of goodwill related to the 1999 acquisition of a 50% interest in WCI. In accordance with ASC 350, “Intangibles-Goodwill and Other,” The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually as of December 31 and whenever events or changes in circumstances indicate carrying amount may not be recoverable. In the impairment test, the Company measures the recoverability of goodwill by comparing a reporting unit’s carrying amount, including goodwill, to the estimated fair value of the reporting unit. If the carrying amount of a reporting unit is in excess of its fair value, the Company recognizes an impairment charge equal to the amount in excess. To estimate the fair value, management uses valuation techniques which included the discounted value of estimated future cash flows. The evaluation of impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and are subject to change as future events and circumstances change. Actual results may differ from assumed and estimated amounts. Management determined that no impairment write-downs were required as of March 31, 2021 and December 31, 2020.

Note 2 - Summary of signific_18

Note 2 - Summary of significant accounting policies: Revenue recognition (Policies)3 Months Ended
Mar. 31, 2021
Policies
Revenue recognitionRevenue recognition The Company recognizes revenue in accordance with ASC 606, “ Revenue from Contracts with Customers Leases WCI works with business park owners, governmental centers, and apartment complexes to reduce facilities related costs. WCI performs monthly services pursuant to agreements with customers. Customer monthly service fees are based on WCI’s assessment of the amount and frequency of monthly services requested by a customer. WCI may also provide additional services, such as apartment cleanout services, large item removals, or similar services, on an as needed basis at an agreed upon rate as requested by customers. All services are invoiced and recognized as revenue in the month the agreed on services are performed. For each finance lease, the Company recognized as a gain the amount equal to (i) the net investment in the finance lease less (ii) the net book value of the equipment at the inception of the applicable lease. At lease inception, we capitalize the total minimum finance lease payments receivable from the lessee, the estimated unguaranteed residual value of the equipment at lease termination, if any, and the initial direct costs related to the lease, less unearned income. Unearned income is recognized as finance income over the term of the lease using the effective interest rate method. The Company, through its subsidiaries, is the lessor of manufacturing equipment subject to leases under master leasing agreements. The leases contain an element of dealer profit and lessee bargain purchase options at prices substantially below the subject assets’ estimated residual values at the exercise date for the options. Consequently, the Company classified the leases as sales-type leases (the “finance leases”) for financial accounting purposes. For such finance leases, the Company reports the discounted present value of (i) future minimum lease payments (including the bargain purchase option, if any) and (ii) any residual value not subject to a bargain purchase option as a finance lease receivable on its balance sheet and accrues interest on the balance of the finance lease receivable based on the interest rate inherent in the applicable lease over the term of the lease. For each finance lease, the Company recognized revenue in an amount equal to the net investment in the lease and cost of sales equal to the net book value of the equipment at the inception of the applicable lease.

Note 2 - Summary of signific_19

Note 2 - Summary of significant accounting policies: Basic and diluted income (loss) per common share (Policies)3 Months Ended
Mar. 31, 2021
Policies
Basic and diluted income (loss) per common shareBasic and diluted income (loss) per common share We compute net income (loss) per share in accordance with ASC 260, “ Earnings Per Share Outstanding warrants that had no effect on the computation of the dilutive weighted average number of shares outstanding as their effect would be anti-dilutive were approximately 7,000,000 and 7,000,000 as of March 31, 2021 and December 31, 2020, respectively. There were 87,456 and 87,456 potentially dilutive shares outstanding at March 31, 2021 and December 31, 2020, respectively. Conversion of Series Q Preferred Stock into Common Stock would be anti-dilutive for the three months ended March 31, 2021 and 2020 and is not included in calculating the diluted weighted average number of shares outstanding.

Note 3 - Prepaid expenses and_2

Note 3 - Prepaid expenses and other assets: Schedule of Prepaid expenses and other assets (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Prepaid expenses and other assets March 31, 2021 December 31, 2020 Prepaid management fees $ 115,000 $ - Prepaid insurance 342 342 Other prepaid costs 28,796 17,497 $ 144,138 $ 17,839

Note 4 - Investment in accoun_2

Note 4 - Investment in account receivable: Schedule of Receivables with Imputed Interest (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Receivables with Imputed Interest March 31, 2021 December 31, 2020 Face value $ 702,000 $ 702,000 Impairment (139,148) (139,148) Unamortized discount (217,566) (232,794) Net balance 345,286 330,058 Current portion (84,662) (26,162) Long term portion $ 260,624 $ 303,896

Note 5 - Property and equipme_2

Note 5 - Property and equipment: Property, Plant and Equipment (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Property, Plant and Equipment March 31, 2021 December 31, 2020 Computers $ 39,809 $ 38,545 Furniture and fixtures 23,428 23,428 Machinery and vehicles 211,782 205,187 275,019 267,160 Accumulated depreciation and amortization (139,395) (129,974) Net Property and equipment $ 135,624 $ 137,186

Note 6 - Lessee Leases_ Schedul

Note 6 - Lessee Leases: Schedule of Lease costs recognized in Consolidated Statements of Operations (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Lease costs recognized in Consolidated Statements of Operations Three Months Ended March 31, 2021 2020 Operating lease cost included in cost of goods $ 32,864 $ 45,956 Operating lease cost included in operating costs 11,096 14,274 Total operating lease cost (1) 43,960 60,230 Finance lease cost, included in cost of goods: Amortization of lease assets 28,518 13,993 Interest on lease liabilities 5,467 3,494 Total finance lease cost 33,985 17,487 Short-term lease cost 2,300 8,970 Total lease cost $ 80,245 $ 86,687

Note 6 - Lessee Leases_ Sched_2

Note 6 - Lessee Leases: Schedule of other information about lease amounts recognized in Condensed Consolidated Financial Statements (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of other information about lease amounts recognized in Condensed Consolidated Financial Statements March 31, 2021 December 31, 2020 Weighted-average remaining lease term – operating leases 1.52 years 0.93 years Weighted-average remaining lease term – finance leases 4.07 years 3.41 years Weighted-average discount rate – operating leases 9.2% 10.1% Weighted-average discount rate – finance leases 5.1% 8.3%

Note 6 - Lessee Leases_ Sched_3

Note 6 - Lessee Leases: Schedule of Finance lease liabilities (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Finance lease liabilities March 31, 2021 December 31, 2020 Gross finance lease liabilities $ 516,408 $ 310,685 Less: imputed interest (45,088) (40,183) Present value of finance lease liabilities 471,320 270,502 Less: current portion (119,542) (79,526) Long-term finance lease liabilities $ 351,778 $ 190,976

Note 6 - Lessee Leases_ Sched_4

Note 6 - Lessee Leases: Schedule of Operating lease liabilities (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Operating lease liabilities March 31, 2021 December 31, 2020 Gross operating lease liabilities $ 161,153 $ 146,171 Less: imputed interest (6,646) (6,863) Present value of operating lease liabilities 154,507 139,308 Less: current portion (121,588) (123,158) Long-term operating lease liabilities $ 32,919 $ 16,150

Note 6 - Lessee Leases_ Sched_5

Note 6 - Lessee Leases: Schedule of Lease Maturities (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Lease Maturities Maturity of lease liabilities 12 months ending March 31, Finance leases Operating leases 2022 $ 119,542 $ 121,588 2023 126,545 32,919 2024 95,883 - 2025 82,029 - 2026 47,321 - Total 471,320 154,507 Less: Current maturities 119,542 121,588 Long-term liability $ 351,778 $ 32,919

Note 7 - Convertible notes re_2

Note 7 - Convertible notes receivable: Schedule of Convertible Notes Receivable (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Convertible Notes Receivable March 31, 2021 December 31, 2020 November 22, 2017, NeuCourt, Inc. convertible note receivable including accrued interest of $1,774 and $1,454 at March 31, 2021 and December 31, 2020. The note bears interest at 5% per annum, originally matured November 22, 2019, and was extended to mature November 22, 2021. Principal and accrued interest are due at maturity. Upon extension, the Company received a cash payment of $2,496 for interest accrued through November 4, 2019. Principal and unpaid interest may be converted into a blend of shares of a to-be-created series of Preferred Stock and Common Stock of NeuCourt (i) on closing of a future financing round of at least $750,000, (ii) on the election of NeuCourt on maturity of the Note, or (iii) on election of Mentor following NeuCourt’s election to prepay the Note. * $ 26,774 $ 26,454 October 31, 2018, NeuCourt, Inc. convertible note receivable including accrued interest of $6,257 and $5,584 at March 31, 2021 and December 31, 2020. The note bears interest at 5% per annum and matures October 31, 2022. Principal and accrued interest are due at maturity. Principal and unpaid interest may be converted into a blend of shares of a to-be-created series of Preferred Stock and Common Stock of NeuCourt (i) on closing of a future financing round of at least $750,000, (ii) on the election of NeuCourt on the maturity of the Note, or (iii) on the election of Mentor following NeuCourt’s election to prepay the Note. * 56,257 55,584 Total convertible notes receivable 83,031 82,038 Less current portion (26,774) (26,454) Long term portion $ 56,257 $ 55,584

Note 8 - Finance leases recei_2

Note 8 - Finance leases receivable: Schedule of Performing net finance leases receivable (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Performing net finance leases receivable March 31, 2021 December 31, 2020 Gross minimum lease payments receivable $ 450,136 $ 477,680 Accrued interest 2,055 2,141 Less: unearned interest (94,539) (103,870) Finance leases receivable 357,652 375,951 Less current portion (70,896) (69,053) Long term portion $ 286,756 $ 306,898

Note 8 - Finance leases recei_3

Note 8 - Finance leases receivable: Schedule of minimum future payments receivable under finance leases (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of minimum future payments receivable under finance leases 12 months ending March 31, Lease Receivable Interest 2022 $ 70,529 $ 39,646 2023 83,163 27,012 2024 92,048 18,127 2025 93,977 8,346 2026 14,664 1,295 Thereafter 1,216 113 $ 355,597 $ 94,539

Note 9 - Contractual interest_2

Note 9 - Contractual interests in legal recoveries: Schedule of Company's interest in the Electrum Partners, LLC legal recovery (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Company's interest in the Electrum Partners, LLC legal recovery March 31, 2021 December 31, 2020 October 30, 2018 Recovery Purchase Agreement $ 181,529 $ 181,529 October 31, 2018 secured Capital Agreement 100,000 100,000 January 28, 2019 secured Capital Agreement 100,000 100,000 Total Invested $ 381,529 $ 381,529

Note 9 - Contractual interest_3

Note 9 - Contractual interests in legal recoveries: Schedule of Hierarchy of Level 1, Level 2 and Level 3 Assets (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Hierarchy of Level 1, Level 2 and Level 3 Assets Fair Value Measurement Using Unadjusted Quoted Market Prices Quoted Prices for Identical or Similar Assets in Active Markets Significant Unobservable Inputs Significant Unobservable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) (Level 3) (Level 3) Investment in Securities Contractual interest Legal Recovery Investment in Common Stock Warrants Other Equity Investments Balance at December 31, 2019 - - 346,195 5,669 204,028 Total gains or losses Included in earnings (or changes in net assets) (10,292) - - (4,669) - Purchases, issuances, sales, and settlements Purchases 83,536 - 50,717 - - Issuances - - - - - Sales (38,418) - - - - Settlements - - (15,383) - - Balance at December 31, 2020 $ 34,826 $ - $ 381,529 $ 1,000 $ 204,028 Total gains or losses Included in earnings (or changes in net assets) 4,850 - - - - Purchases, issuances, sales, and settlements Purchases - - - - - Issuances - - - - - Sales - - - - - Settlements - - - - - Balance at March 31, 2021 $ 39,676 $ - $ 381,529 $ 1,000 $ 204,028

Note 9 - Contractual interest_4

Note 9 - Contractual interests in legal recoveries: Schedule of Amortized costs, gross unrealized holding gains and losses, and fair values of the Company's investment securities (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Amortized costs, gross unrealized holding gains and losses, and fair values of the Company's investment securities Type Amortized Costs Gross Unrealized Gains Gross Unrealized Losses Fair Values NYSE listed company stock $ 10,080 $ (1,167) $ - $ 8,913 NASDAQ listed company stock 35,341 (4,578) - 30,763 $ 45,421 $ (5,745) $ - $ 39,676

Note 9 - Contractual interest_5

Note 9 - Contractual interests in legal recoveries: Schedule of Portion of unrealized gains and losses for the period related to equity securities still held (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Portion of unrealized gains and losses for the period related to equity securities still held Three Months Ended March 31, 2021 2020 Net gains and losses recognized during the period on equity securities $ 4,849 $ (5,037) Less: Net gains (losses) recognized during the period on equity securities sold during the period - - Unrealized gains and losses recognized during the reporting period on equity securities still held at the reporting date $ 4,849 $ (5,037)

Note 11 - Common stock warran_2

Note 11 - Common stock warrants: Schedule of Series B and Series D common stock warrants (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Series B and Series D common stock warrants Series B Series D B and D Total Outstanding at December 31, 2019 87,456 6,252,954 6,340,410 Issued - - - Exercised - - - Outstanding at December 31, 2020 87,456 6,252,954 6,340,410 Issued - - - Exercised - - - Outstanding at March 31, 2021 87,456 6,252,954 6,340,410

Note 11 - Common stock warran_3

Note 11 - Common stock warrants: Schedule of Series E, F, G and H warrants (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Series E, F, G and H warrants Series H $7.00 exercise price Outstanding at December 31, 2019 689,159 Issued - Exercised - Outstanding at December 31, 2020 689,159 Issued - Exercised - Outstanding at March 31, 2021 689,159

Note 14 - Term Loan_ Schedule o

Note 14 - Term Loan: Schedule of Term Debt (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Term Debt March 31, 2021 December 31, 2020 Bank of America auto loan, interest at 2.37% per annum, monthly principal and interest payments of $1,448, maturing December 2025, collateralized by vehicle. 77,983 $ 81,812 Less: Current maturities (15,696) (15,566) $ 62,287 $ 66,246

Note 15 - Paycheck Protection_2

Note 15 - Paycheck Protection Plan Loans and Economic Injury Disaster Loans: Schedule of Paycheck protection plan loan balances (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Paycheck protection plan loan balances March 31, 2021 December 31, 2020 May 5, 2020, PPP loan from Republic Bank of Arizona to Waste Consolidators, Inc., revised December 1, 2020. The note bears interest at 1% per annum, with a revised maturation date of May 15, 2020, with monthly principal and interest payments of $560 beginning December 15, 2020. On March 16, 2021, WCI was notified of full forgiveness of the note. $ - $ 9,449 February 17, 2021, Second PPP loan from the Bank of Southern California, with accrued interest of $88 at March 31, 2021. The loan bears interest at 1% per annum and matures January 16, 2026. Mentor may apply for forgiveness for amounts disbursed for covered costs. Payment on any unforgiven amount begins within ten months after last day of the loan forgiveness covered period (i) beginning on the date that is 8 weeks after the date of disbursement and (ii) ending on the date that is 24 weeks after the date of disbursement. 76,681 - Total 76,681 9,449 Less: Current maturities - (6,658) Long-term portion of paycheck protection plan loans $ 76,681 $ 2,791

Note 15 - Paycheck Protection_3

Note 15 - Paycheck Protection Plan Loans and Economic Injury Disaster Loans: Schedule of EIDL loan balances (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of EIDL loan balances March 31, 2021 December 31, 2020 July 9, 2020, WCI received an additional Economic Injury Disaster Loan, including accrued interest of $4,093 and $2,502 as of March 31, 2021 and December 31, 2020, respectively. The note is secured by all tangible and intangible personal property of WCI, bears interest at 3.75% per annum, requires monthly installment payments of $731 beginning July 2021, and matures July 2050. $ $ 153,993 $ 152,602 Less: Current maturities - - Long-term portion of economic injury disaster loan $ $ 153,993 $ 152,602

Note 16 - Accrued salary, acc_2

Note 16 - Accrued salary, accrued retirement, and incentive fee - related party: Schedule of Outstanding Liability (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Outstanding Liability March 31, 2021 December 31, 2020 Accrued salaries and benefits $ 856,784 $ 848,796 Accrued retirement and other benefits 510,538 550,191 Offset by shareholder advance (261,653) (261,653) $ 1,105,669 $ 1,137,334

Note 19 - Segment Information_

Note 19 - Segment Information: Schedule of Segment Information (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Schedule of Segment Information Cannabis and Medical Marijuana Segment Facility Operations Related Corporate, Other and Eliminations Consolidated Three months ended March 31, 2021 Net revenue $ 10,871 $ 1,309,753 $ - $ 1,320,624 Operating income (loss) 6,125 (3,946) (166,922) (164,743) Interest income - - 16,489 16,489 Interest expense - 8,498 3,572 12,070 Property additions - 6,595 1,264 7,859 Depreciation and amortization - 7,960 1,461 9,421 Total assets 1,005,990 2,124,769 1,644,546 4,775,305 Three months ended March 31, 2020 Net revenue $ 12,538 $ 1,136,924 $ - $ 1,149,462 Operating income (loss) (8,905) 34,176 (261,994) (236,723) Interest income 24 - 19,379 19,403 Interest expense - 8,471 (1,134) 7,337 Property additions - 3,329 - 3,329 Depreciation and amortization - 2,640 1,202 3,842 Total assets 2,343,236 1,657,984 764,633 4,765,853

Note 19 - Segment Information_2

Note 19 - Segment Information: Reconciliation of Revenue from Segments to Consolidated (Tables)3 Months Ended
Mar. 31, 2021
Tables/Schedules
Reconciliation of Revenue from Segments to Consolidated Three Months Ended March 31, 2021 2020 Operating loss $ (164,743) $ (236,723) Gain (loss) on investments in securities 4,849 (5,037) Gain (loss) on long-term investments - (5,169) Paycheck Protection Program Loan forgiveness 10,000 - Interest income 16,849 19,403 Interest expense (12,070) (7,337) Loss on ROU asset disposal (643) - Other income (expense) (1,053) 12,084 Income before income taxes $ (147,171) $ (222,779)

Note 1 - Nature of operations (

Note 1 - Nature of operations (Details)3 Months Ended
Mar. 31, 2021
Details
Entity Incorporation, State or Country CodeDE
Entity Incorporation, Date of IncorporationJul. 29,
1994

Note 2 - Summary of signific_20

Note 2 - Summary of significant accounting policies: Goodwill (Details)Mar. 31, 2021USD ($)
Details
Goodwill from consolidating WCI $ 1,324,142

Note 3 - Prepaid expenses and_3

Note 3 - Prepaid expenses and other assets: Schedule of Prepaid expenses and other assets (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
Prepaid management fees $ 115,000 $ 0
Prepaid insurance342 342
Other prepaid costs28,796 17,497
Prepaid expenses and other current assets $ 144,138 $ 17,839

Note 4 - Investment in accoun_3

Note 4 - Investment in account receivable: Schedule of Receivables with Imputed Interest (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
Face value $ 702,000 $ 702,000
Impairment(139,148)(139,148)
Unamortized discount(217,566)(232,794)
Net balance345,286 330,058
Current portion *(84,662)(26,162)
Long term portion $ 260,624 $ 303,896

Note 4 - Investment in accoun_4

Note 4 - Investment in account receivable (Details) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Details
Discount Amortization included in Interest Income $ 15,228 $ 18,345

Note 5 - Property and equipme_3

Note 5 - Property and equipment: Property, Plant and Equipment (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
Computers $ 39,809 $ 38,545
Furniture and fixtures23,428 23,428
Machinery and vehicles211,782 205,187
Property and equipment275,019 267,160
Accumulated depreciation and amortization(139,395)(129,974)
Property and equipment, net $ 135,624 $ 137,186

Note 5 - Property and equipme_4

Note 5 - Property and equipment (Details) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Details
Depreciation, Depletion and Amortization, Nonproduction $ 9,421 $ 3,842

Note 6 - Lessee Leases_ Sched_6

Note 6 - Lessee Leases: Schedule of Lease costs recognized in Consolidated Statements of Operations (Details) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Details
Operating lease cost included in cost of goods $ 32,864 $ 45,956
Operating lease cost included in operating costs11,096 14,274
Total operating lease cost[1]43,960 60,230
Amortization of lease assets28,518 13,993
Interest on lease liabilities5,467 3,494
Total finance lease cost33,985 17,487
Short-term lease cost2,300 8,970
Total lease cost $ 80,245 $ 86,687
[1]Right of use asset amortization under operating agreements was $40,981 and $45,896 for the three months ended March 31, 2021 and 2020, respectively.

Note 6 - Lessee Leases (Details

Note 6 - Lessee Leases (Details) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Details
Rental expense under operating agreements $ 40,981 $ 45,896

Note 6 - Lessee Leases_ Sched_7

Note 6 - Lessee Leases: Schedule of other information about lease amounts recognized in Condensed Consolidated Financial Statements (Details)Mar. 31, 2021Dec. 31, 2020
Details
Weighted-average remaining lease term –operating leases1 year 6 months 7 days11 months 5 days
Weighted-average remaining lease term –finance leases4 years 25 days3 years 4 months 28 days
Weighted-average discount rate –operating leases9.20%10.10%
Weighted-average discount rate –finance leases5.10%8.30%

Note 6 - Lessee Leases_ Sched_8

Note 6 - Lessee Leases: Schedule of Finance lease liabilities (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
Gross finance lease liabilities $ 516,408 $ 310,685
Less: imputed interest(45,088)(40,183)
Present value of finance lease liabilities471,320 270,502
Less: current portion(119,542)(79,526)
Long-term finance lease liabilities $ 351,778 $ 190,976

Note 6 - Lessee Leases_ Sched_9

Note 6 - Lessee Leases: Schedule of Operating lease liabilities (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
Gross operating lease liabilities $ 161,153 $ 146,171
Less: imputed interest(6,646)(6,863)
Present value of operating lease liabilities154,507 139,308
Less: current portion(121,588)(123,158)
Long-term operating lease liabilities $ 32,919 $ 16,150

Note 7 - Convertible notes re_3

Note 7 - Convertible notes receivable: Schedule of Convertible Notes Receivable (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
NeuCourt, Inc. convertible note receivable 2[1] $ 26,774 $ 26,454
NeuCourt, Inc. second convertible note receivable[1]56,257 55,584
Total convertible notes receivable83,031 82,038
Less current portion(26,774)(26,454)
Long term portion $ 56,257 $ 55,584
[1]The Conversion Price for each Note is the lower of (i) 75% of the price paid in the Next Equity Financing, or the price obtained by dividing a $3,000,000 valuation cap by the fully diluted number of shares. The number of Conversion Shares issued on conversion shall be the quotient obtained by dividing the outstanding principal and unpaid accrued interest on a Note to be converted on the date of conversion by the Conversion Price (the “Total Number of Shares”), The Total Number of Shares shall consist of Preferred Stock and Common Stock as follows: (i) That number of shares of Preferred Stock obtained by dividing (a) the principal amount of each Note and all accrued and unpaid interest thereunder by (b) the price per share paid by other purchasers of Preferred Stock in the Next Equity Financing (such number of shares, the 'Number of Preferred Stock') and (ii) that number of shares of Common Stock equal to the Total Number of Shares minus the Number of Preferred Stock. Using the valuation cap of $3,000,000, the November 22, 2017 Note would convert into 99,959 Conversion Shares and the October 31, 2018 Note would convert into 210,027 Conversion Shares at March 31, 2021. In the event of a Corporate Transaction prior to repayment or conversion of the Note, the Company shall receive back two times the outstanding principal on the Note, plus all accrued unpaid interest.

Note 8 - Finance leases recei_4

Note 8 - Finance leases receivable: Schedule of Performing net finance leases receivable (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
Gross minimum lease payments receivable $ 450,136 $ 477,680
Accrued interest2,055 2,141
Less: unearned interest(94,539)(103,870)
Finance leases receivable357,652 375,951
Less current portion(70,896)(69,053)
Long term portion $ 286,756 $ 306,898

Note 11 - Common stock warran_4

Note 11 - Common stock warrants (Details)3 Months Ended
Mar. 31, 2021USD ($)$ / sharessharesMar. 31, 2020sharesDec. 31, 2020USD ($)$ / shares
Details
Warrants issued, Average Contractual Life in Years17.3 17.5
Weighted Average outstanding warrant exercise price | $ / shares $ 2.11 $ 2.11
Warrants exercised in period, Total0 0
Warrants issued in period, Total0 0
Warrants issued in period, Intrinsic Value | $ $ 5,247 $ 0

Note 11 - Common stock warran_5

Note 11 - Common stock warrants: Schedule of Series B and Series D common stock warrants (Details) - shares3 Months Ended12 Months Ended
Mar. 31, 2021Dec. 31, 2020
Series B
Warrants Outstanding, Starting Balance87,456 87,456
Warrants Issued0 0
Warrants Exercised0 0
Warrants Outstanding, Ending Balance87,456 87,456
Series D
Warrants Outstanding, Starting Balance6,252,954 6,252,954
Warrants Issued0 0
Warrants Exercised0 0
Warrants Outstanding, Ending Balance6,252,954 6,252,954
B and D Total
Warrants Outstanding, Starting Balance6,340,410 6,340,410
Warrants Issued0 0
Warrants Exercised0 0
Warrants Outstanding, Ending Balance6,340,410 6,340,410

Note 11 - Common stock warran_6

Note 11 - Common stock warrants: Schedule of Series E, F, G and H warrants (Details) - Series H $7.00 exercise price - shares3 Months Ended12 Months Ended
Mar. 31, 2021Dec. 31, 2020
Warrants Outstanding, Starting Balance689,159 689,159
Warrants Issued0 0
Warrants Exercised0 0
Warrants Outstanding, Ending Balance689,159 689,159

Note 13 - Stockholders' equity

Note 13 - Stockholders' equity (Details) - $ / sharesMar. 31, 2021Dec. 31, 2020
Details
Common Stock, Shares Authorized75,000,000 75,000,000
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized[1]5,000,000 5,000,000
Preferred Stock, Par or Stated Value Per Share[1] $ 0.0001 $ 0.0001
[1]* Par value is less than $0.01.

Note 16 - Accrued salary, acc_3

Note 16 - Accrued salary, accrued retirement, and incentive fee - related party: Schedule of Outstanding Liability (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Details
Accrued salaries and benefits $ 856,784 $ 848,796
Accrued retirement and other benefits510,538 550,191
Offset by shareholder advance(261,653)(261,653)
Total Outstanding Liabilities $ 1,105,669 $ 1,137,334

Note 19 - Segment Information_3

Note 19 - Segment Information: Schedule of Segment Information (Details) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Operating income (loss) $ (164,743) $ (236,723)
Interest income16,489 19,403
Interest expense12,070 7,337
Cannabis and Medical Marijuana Segment
Net revenue10,871 12,538
Operating income (loss)6,125 (8,905)
Interest income0 24
Interest expense0 0
Property additions0 0
Depreciation and amortization0 0
Total assets1,005,990 2,343,236
Facility Operations Related
Net revenue1,309,753 1,136,924
Operating income (loss)(3,946)34,176
Interest income0 0
Interest expense8,498 8,471
Property additions6,595 3,329
Depreciation and amortization7,960 2,640
Total assets2,124,769 1,657,984
Corporate and Eliminations
Net revenue0 0
Operating income (loss)(166,922)(261,994)
Interest income16,489 19,379
Interest expense3,572 (1,134)
Property additions1,264 0
Depreciation and amortization1,461 1,202
Total assets1,644,546 764,633
Consolidated
Net revenue1,320,624 1,149,462
Operating income (loss)(164,743)(236,723)
Interest income16,489 19,403
Interest expense12,070 7,337
Property additions7,859 3,329
Depreciation and amortization9,421 3,842
Total assets $ 4,775,305 $ 4,765,853

Note 19 - Segment Information_4

Note 19 - Segment Information: Reconciliation of Revenue from Segments to Consolidated (Details) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Details
Segment Reconciliation, Operating Loss $ (164,743) $ (236,723)
Segment Reconciliation, Gain (Loss) on Investments4,849 (5,037)
Segment Reconciliation, Gain (loss) on long-term investments0 (5,169)
Segment Reconciliation, Paycheck Protection Program Loan forgiveness10,000 0
Segment Reconciliation, Interest income16,849 19,403
Segment Reconciliation, Interest Expense(12,070)(7,337)
Segment Reconciliation, Loss on ROU asset disposal(643)0
Segment Reconciliation - Other income(1,053)12,084
Segment Reconciliation, Income before income taxes $ (147,171) $ (222,779)

Note 20 - Subsequent events (De

Note 20 - Subsequent events (Details)3 Months Ended
Mar. 31, 2021
Event #1
Subsequent Event, DescriptionLori Stansfield will no longer serve as the Company’s Chief Financial Officer
Event #2
Subsequent Event, DescriptionStan Shaul will no longer be able to serve as a board member and audit committee member
Subsequent Event, DateMay 15,
2021